{"study_id": 48182, "supplement_id": 1557, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of micelle silymarin (MS) supplementation on the performance, egg quality, water loss, and blood profile of laying hens.", "results_summary": "MS supplementation linearly improved Haugh units, egg weight, eggshell strength, albumen height, and eggshell thickness while reducing egg yolk color and water loss. It also decreased aspartate aminotransferase and cholesterol levels without affecting hens' growth performance.", "population_specificity": "288 Hy-Line brown laying hens, 28 weeks old.", "effective_dosage": "0%, 0.03%, and 0.06% of the basal diet.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:22:57.341591+00:00"}
{"study_id": 48184, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how silymarin and a polyherbal extract interact with gut microbiota to ameliorate non-alcoholic fatty liver disease (NAFLD) in mice.", "results_summary": "Silymarin and the polyherbal extract significantly improved liver steatosis and function, increased beneficial probiotics (Akkermansia, Blautia), and suppressed harmful bacteria (Clostridium), linked to changes in bile acids. Fecal microbiome transplantation confirmed these microbiota alterations were responsible for NAFLD improvement.", "population_specificity": "C57BL/6J mice with HFD-induced NAFLD.", "effective_dosage": "Medium and high doses of Silybum marianum extract (containing silymarin) or polyherbal extract (containing silymarin, salvianolic acids B, and puerarin); exact amounts not specified.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:00.728738+00:00"}
{"study_id": 48185, "supplement_id": 1557, "safety_score": "20", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective and therapeutic effects of silymarin and dexmedetomidine on lung and kidney tissue in rats with sepsis induced by the cecal ligation and puncture method.", "results_summary": "Silymarin administration increased kidney damage compared to the sepsis-only group, while dexmedetomidine reduced kidney damage. Co-administration of both partially ameliorated injury but was less effective than dexmedetomidine alone.", "population_specificity": "Rats with sepsis induced by cecal ligation and puncture.", "effective_dosage": "100 mg/kg silymarin administered intraperitoneally.", "study_duration": "Single dose administered 1 hour before or after sepsis induction.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:02.312205+00:00"}
{"study_id": 48186, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the kidney protective effects of silymarin against thioacetamide-induced renal fibrosis in rats, comparing its efficacy to exosomes of mesenchymal stem cells.", "results_summary": "Silymarin significantly reversed thioacetamide-induced increases in serum urea, creatinine, TGF-\u03b2 receptor expression, collagen I, CTGF proteins, and SMAD proteins, though exosomes showed superior efficacy in restoring some markers to near-control levels.", "population_specificity": "Female rats with thioacetamide-induced renal fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:03.269226+00:00"}
{"study_id": 48187, "supplement_id": 1557, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to develop and characterize silymarin-loaded niosomes as a drug delivery system, evaluating their stability, release behavior, and therapeutic potential.", "results_summary": "The study found that silymarin-loaded niosomes exhibited high encapsulation efficiency (91%), sustained release, improved antimicrobial and cytotoxic effects, and favorable safety profiles in vivo compared to bulk silymarin.", "population_specificity": "Not specified (in vitro and in vivo evaluations, but no human subjects mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:04.274239+00:00"}
{"study_id": 48188, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of Silymarin in regulating energy metabolism, attenuating liver damage, and improving liver histology in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Silymarin significantly reduced levels of TC, TG, LDL-C, FI, HOMA-IR, ALT, AST, fatty liver index, and fatty liver score while increasing HDL-C. It also improved hepatic steatosis in liver histology.", "population_specificity": "2,375 patients with NAFLD across 26 randomized controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:05.148980+00:00"}
{"study_id": 48191, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding Silymarin to GelMA bioink could protect bioprinted liver tissue from oxidative stress and drug-induced hepatotoxicity.", "results_summary": "Silymarin improved albumin synthesis and protected liver tissue from CCl4-induced damage, reducing TNF-\u03b1 and enhancing SOD expression in HepG2 cells.", "population_specificity": "HepG2 cells (liver cancer cell line) in a bioprinted liver construct.", "effective_dosage": "Concentration optimized but not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:05.592157+00:00"}
{"study_id": 48189, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of silymarin antioxidant serum, both alone and in combination with prescription acne treatments, on improving facial appearance in blemish-prone skin.", "results_summary": "Silymarin reduced inflammatory lesions by 45% and noninflammatory lesions by 43% in one study, while another study showed reductions in facial erythema (60%), dryness (49%), and scaling (67%) when used alongside prescription acne therapy. It also decreased oiliness by 16% and improved markers of skin aging.", "population_specificity": "Blemish-prone individuals in Brazil (56 subjects) and acne patients on prescription medications in the US/Germany (40 subjects).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:06.619273+00:00"}
{"study_id": 48190, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if combining silymarin with antiviral therapy (AVT) could reduce mortality and hepatocellular carcinoma (HCC) incidence in patients with HBV-related liver cirrhosis (HBV-LC).", "results_summary": "The study found that silymarin combined with AVT significantly improved mortality outcomes and comorbidity indices but did not affect HCC occurrence. The case cohort showed better one-year and two-year survival rates compared to the control group.", "population_specificity": "8447 HBV-LC patients (after matching, 319 in each cohort) undergoing AVT.", "effective_dosage": "Not specified", "study_duration": "At least 30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:06.826299+00:00"}
{"study_id": 48192, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Silymarin on biochemical and transaminase levels in patients with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD).", "results_summary": "Silymarin significantly reduced ALT, AST, and TG levels while improving HDL. No significant effects were observed for GGT, TC, LDL, HOMA-IR, or BMI, though one study noted fibrosis improvement.", "population_specificity": "Patients with NAFLD/MASLD", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:08.349274+00:00"}
{"study_id": 48193, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether silymarin could mitigate the negative effects of aflatoxin B1 on rat body weight and reproductive organs.", "results_summary": "Silymarin improved growth, reproductive organ health, and gene expression (TNF-\u03b1, LHR, StAR) while restoring normal testicular architecture in rats exposed to aflatoxin B1. It also counteracted the toxin's negative effects on body weight and testosterone levels.", "population_specificity": "Mature male Wistar white rats (average weight 83.67 \u00b1 0.21 g).", "effective_dosage": "20 mg/kg body weight, orally.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:11.444533+00:00"}
{"study_id": 48194, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of micelle silymarin (MS) supplementation on productive performance, egg quality, and blood biochemical parameters in laying hens.", "results_summary": "MS supplementation linearly improved egg production percentage, egg weight, feed conversion ratio, feed intake, eggshell thickness, and eggshell strength, while reducing cholesterol levels in hens. Eggshell color, Haugh unit, and albumin height showed no significant differences, but yolk color improved at higher MS levels.", "population_specificity": "384 Hy-Line brown laying hens (28-week-old).", "effective_dosage": "0%, 0.02%, 0.04%, and 0.06% of MS added to the basal diet.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:12.881511+00:00"}
{"study_id": 48198, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether silymarin alone could improve insulin resistance (IR) in non-diabetic, insulin-resistant women with obesity.", "results_summary": "Silymarin significantly reduced fasting plasma glucose and HOMA-IR levels after 12 weeks, suggesting potential benefits for IR. Other metabolic parameters (e.g., cholesterol, triglycerides) showed non-significant improvements.", "population_specificity": "Non-diabetic, insulin-resistant women with type 1 or type 2 obesity.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:12.976249+00:00"}
{"study_id": 48199, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of a novel hydrogel containing silymarin (SM) and levofloxacin (LEV) to accelerate third-degree burn wound healing.", "results_summary": "The hydrogel significantly accelerated wound closure (98.1% vs. 75.1% in controls) by day 21, with histopathological analysis showing reduced inflammation, likely due to the antioxidant and antibiotic properties of silymarin and levofloxacin.", "population_specificity": "Third-degree burn wound patients (animal or human model not specified in abstract).", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:14.745145+00:00"}
{"study_id": 48200, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effect of Silymarin consumption on inflammation and oxidative stress factors through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Silymarin significantly reduced CRP, MDA, and IL-6 levels, indicating anti-inflammatory and antioxidant effects, but had no significant impact on IL-10, TAC, or GSH. A non-linear relationship was observed between intervention duration and MDA changes.", "population_specificity": "Patients with diabetes and thalassemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:14.751711+00:00"}
{"study_id": 48197, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the influence of a phytogenic feed additive containing silymarin and silymarin alone on broilers' productive performance and liver function, with and without induced liver damage.", "results_summary": "The study found that the phytogenic feed additive (CA-PFA) improved body weight gain and feed conversion ratio in broilers, both with and without induced liver damage, compared to a basal diet and standard silymarin. Silymarin alone was used as a reference due to its known hepatoprotective properties, but the abstract does not detail its standalone efficacy.", "population_specificity": "One-day-old male broilers (Cobb Vantress 500).", "effective_dosage": "70 mg/kg of silymarin (provided via CA-PFA at 500 mg/kg feed or silymarin at 250 mg/kg feed).", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:15.315095+00:00"}
{"study_id": 48202, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of silymarin on oxidative stress biomarkers, inflammation, and disease severity in Alzheimer's patients.", "results_summary": "Silymarin significantly reduced catalase and MDA serum levels and notably increased MMSE scores, indicating reduced oxidative stress and improved cognitive function in Alzheimer's patients.", "population_specificity": "33 patients with Alzheimer's disease confirmed by DSM-5 criteria and brain imaging.", "effective_dosage": "Three 250 mg silymarin capsules daily (each containing 150 mg silymarin).", "study_duration": "One trimester (approximately 3 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:16.862668+00:00"}
{"study_id": 48201, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of silymarin and the MAPK pathway in regulating the proliferation and invasion of non-small cell lung cancer cells.", "results_summary": "Silymarin inhibited the proliferation and invasion of non-small cell lung cancer cells, with higher concentrations showing more pronounced effects. It reduced the expression of MMP-2, MMP-9, p-p38, and p-JNK, suggesting inhibition of the MAPK pathway.", "population_specificity": "Non-small cell lung cancer cells in vitro.", "effective_dosage": "10 mg/L, 20 mg/L, and 40 mg/L.", "study_duration": "24h and 48h after treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:17.287480+00:00"}
{"study_id": 48203, "supplement_id": 1557, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate silymarin's hepatoprotective, antioxidant, anti-inflammatory, and antifibrotic properties for managing chronic liver diseases.", "results_summary": "Silymarin demonstrated potential as an efficacious and tolerable herbal product for liver disease management, showing hepatoprotective and therapeutic effects. The study highlights its promise but notes no approved drug therapy currently exists for these conditions.", "population_specificity": "Patients with chronic liver diseases, including non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, drug-induced liver injury, and alcoholic liver disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:21.300091+00:00"}
{"study_id": 48204, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of silymarin compared to rosuvastatin and placebo on neuro-metabolites, serum levels of LRP1 and A\u03b21-42 proteins, oxidative stress enzymes, lipid profiles, and cognitive tests in mild Alzheimer's disease (AD) patients.", "results_summary": "Silymarin significantly increased LRP1 and A\u03b21-42 levels, improved NAA/mI ratios, and showed correlations with lipid profiles and neurometabolites, suggesting potential benefits in AD pathology.", "population_specificity": "Iranian patients with mild Alzheimer's disease (n=12 per group).", "effective_dosage": "140mg, administered 3 times daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:21.770217+00:00"}
{"study_id": 48205, "supplement_id": 1557, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of oral silymarin on hepatic function in pediatric patients with acute lymphoblastic leukemia (ALL).", "results_summary": "Silymarin intake resulted in a slight but significant decrease in ALT, AST, GGT, and bilirubin levels, but had no effect on ALP, albumin, and cholesterol. The study suggests silymarin improves liver function in pediatric ALL patients.", "population_specificity": "Pediatric patients (over 5 years of age) with acute lymphoblastic leukemia (ALL).", "effective_dosage": "70 mg oral capsules twice daily or syrup (5 ml containing 50 mg silymarin) three times a day.", "study_duration": "9 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:21.832477+00:00"}
{"study_id": 48207, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the effects of co-treatment with Silymarin (SLM) and Cisplatin (Cis) on A2780 human ovarian cancer cell lines, focusing on viability, migration, colony formation, apoptosis, and miRNA expression.", "results_summary": "SLM significantly reduced A2780 cell proliferation in a concentration- and time-dependent manner. Combined SLM and Cis treatment was more effective than either alone in reducing viability, suppressing migration, inhibiting colony formation, promoting apoptosis, and altering miR-155 and miR-27a expression.", "population_specificity": "A2780 human ovarian cancer cell lines", "effective_dosage": "Various concentrations (not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:24.233676+00:00"}
{"study_id": 48206, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer effects of niosomal encapsulated silymarin, alone and in combination with quercetin, on diethylnitrosamine-induced hepatocellular carcinoma in rats.", "results_summary": "The combination of niosomal encapsulated silymarin and quercetin (50 mg/kg) showed significant restoration of biomarkers (alpha-fetoprotein, carcinoembryonic antigen) and antioxidants (superoxide dismutase, nitric oxide), along with improved liver architecture in histopathological examination.", "population_specificity": "Male rats with diethylnitrosamine-induced hepatocellular carcinoma.", "effective_dosage": "50 mg/kg of niosomal encapsulated silymarin (alone or in combination with quercetin).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:24.514365+00:00"}
{"study_id": 48208, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antiproliferative and antitelomerase effects of silymarin on human colorectal cancer and hepatocyte carcinoma cells.", "results_summary": "Silymarin inhibited cell proliferation and telomerase activity in all tested cancer cells, with IC50 values ranging from 19\u201356.3 \u00b5g/mL. It also downregulated human telomerase reverse transcriptase expression but did not affect promoter methylation.", "population_specificity": "Human colorectal cancer and HepG2 hepatocyte carcinoma cell lines.", "effective_dosage": "10, 30, and 60 \u00b5g/mL for 48 h; IC50 concentrations (19\u201356.3 \u00b5g/mL) for 30 min.", "study_duration": "24 h to 48 h.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:24.716036+00:00"}
{"study_id": 48209, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to improve Silymarin's solubility and therapeutic activity by developing solid dispersions using different carriers and methods, and to evaluate its anti-cancer effects.", "results_summary": "The study found that ternary solid dispersions significantly enhanced Silymarin's solubility and drug release, with F9 showing the greatest improvement. The cell viability assay demonstrated enhanced anti-cancer activity compared to free Silymarin.", "population_specificity": "Lung cancer cell line (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:24.910289+00:00"}
{"study_id": 48211, "supplement_id": 1557, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining iron with Silymarin nanoliposomes (SLM Lip) could shift its antioxidant properties to prooxidant activity, enhancing cytotoxicity against cancer cells and improving therapeutic outcomes in a breast cancer model.", "results_summary": "The study found that Fe + SLM Lip induced greater toxicity in 4T1 breast cancer cells compared to SLM Lip alone, reduced catalase activity time-dependently, and demonstrated superior therapeutic efficacy in a mouse breast cancer model, leading to longer survival and significant tumor necrosis without major organ damage.", "population_specificity": "Mice bearing 4T1 breast cancer tumors.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Iron sucrose was noted to enhance the prooxidant and cytotoxic effects of SLM Lip.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:28.321590+00:00"}
{"study_id": 48214, "supplement_id": 1557, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of topical silymarin cream compared to salicylic acid peels for treating mild to moderate acne vulgaris.", "results_summary": "Silymarin cream showed comparable efficacy to salicylic acid peels in reducing acne severity, with no reported side effects, while hyperpigmentation occurred in some cases with salicylic acid.", "population_specificity": "30 patients with mild to moderate acne vulgaris.", "effective_dosage": "1.4% silymarin cream applied twice daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:30.400469+00:00"}
{"study_id": 48212, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Silymarin could protect against testicular ischemia-reperfusion (I/R) injury in rats by evaluating histopathological and biochemical parameters.", "results_summary": "Silymarin significantly improved total antioxidant status (TAS) and reduced total oxidant status (TOS), as well as mitigated testicular damage (Johnson score) and inflammation/apoptosis markers (Bax and Annexin V immunostaining) compared to the untreated I/R group. No significant differences were found in MDA, MPO, or GSH levels.", "population_specificity": "Male Wistar albino rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:30.576006+00:00"}
{"study_id": 48213, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective efficacy of testosterone and silymarin (TNSN) against oxidative stress and inflammation in the liver of rats with type 2 diabetes and obesity (DMOB).", "results_summary": "The study found that TNSN treatment effectively normalized abnormal levels of body mass, serum markers, glucose, HbA1c, lipid profiles, antioxidants, inflammatory cytokines, and gene expression pathways in DMOB rats, demonstrating significant protective effects against liver abnormalities.", "population_specificity": "Male Sprague-Dawley rats with induced type 2 diabetes and obesity (DMOB).", "effective_dosage": "Not specified", "study_duration": "20 weeks (with STZ injection on the 9th week)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:31.574451+00:00"}
{"study_id": 48216, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether silymarin (SIL) could mitigate liver injury induced by ethanol and LPS in mice, focusing on antioxidant and anti-inflammatory effects.", "results_summary": "Silymarin (200 mg/kg) did not prevent increased liver enzyme levels, restore glutathione or malonaldehyde levels, or improve antioxidant enzyme activity. It also failed to reduce microsteatosis or inflammatory markers (IL-6, IL-10) compared to NAC.", "population_specificity": "Mice exposed to ethanol and LPS-induced liver injury.", "effective_dosage": "200 mg/kg, orally once daily.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:33.028754+00:00"}
{"study_id": 48217, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective effects of silymarin against 3-NP-induced neurotoxicity in mice, focusing on behavioral, oxidative, and inflammatory outcomes.", "results_summary": "Silymarin significantly attenuated 3-NP-induced behavioral deficits, oxidative stress, and neuroinflammation in both pretreatment and treatment protocols, suggesting its neuroprotective potential via mitigation of oxidative stress.", "population_specificity": "Six-week-old male mice", "effective_dosage": "70 mg/kg/day, orally", "study_duration": "2 weeks pretreatment or 4 weeks post-3-NP administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:33.468923+00:00"}
{"study_id": 48218, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of silymarin against cadmium-induced oxidative stress and liver damage in rats, as well as its ability to restore normal enzyme activities.", "results_summary": "Silymarin restored antioxidant enzyme activities, reduced oxidative stress markers, and normalized drug-metabolizing enzyme levels in cadmium-exposed rats. It also mitigated liver damage, showing comparable efficacy to garlic extract and synergistic effects when combined.", "population_specificity": "Male rats exposed to cadmium chloride.", "effective_dosage": "25 mg/kg, administered orally for 28 consecutive days.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:33.677220+00:00"}
{"study_id": 48219, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of silymarin on Nile tilapia against oxytetracycline-induced immunosuppression and Aeromonas hydrophila infection.", "results_summary": "Silymarin improved blood parameters, reduced mortality by 37%, enhanced antioxidative enzyme levels, and modulated immune responses in Nile tilapia infected with A. hydrophila.", "population_specificity": "Nile tilapia (Oreochromis niloticus)", "effective_dosage": "100 mg/kg fish feed", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:36.642887+00:00"}
{"study_id": 48220, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the protective effects of silymarin against hepatotoxic damage induced by diazinon in rainbow trout.", "results_summary": "Silymarin mitigated oxidative stress and restored enzyme activities in fish exposed to diazinon, maintaining normal levels of glucose, triglycerides, cholesterol, and proteins. However, it had limited effectiveness on creatine phosphokinase, glutathione reductase, and ammonia excretion.", "population_specificity": "Rainbow trout", "effective_dosage": "400 mg kg-1", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:38.288517+00:00"}
{"study_id": 197566, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the effect of silymarin supplementation on blood lipids in adults, particularly its impact on total cholesterol, LDL, HDL, and triglycerides.", "results_summary": "Silymarin supplementation in combination with other treatments reduced total cholesterol and LDL, increased HDL, and significantly lowered triglycerides compared to controls.", "population_specificity": "Adults with hyperlipidemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:40.166089+00:00"}
{"study_id": 197565, "supplement_id": 1557, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether silymarin supplementation could reduce toxicities, particularly diarrhea, in metastatic colorectal cancer patients undergoing irinotecan-based chemotherapy.", "results_summary": "The study found that the silymarin group experienced fewer adverse events of diarrhea (5.7% vs. 14.6%) compared to the control group, suggesting a potential benefit in reducing irinotecan-induced toxicity.", "population_specificity": "Metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab.", "effective_dosage": "150 mg three times daily for 7 days per treatment cycle.", "study_duration": "7 days per treatment cycle (total duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:40.218297+00:00"}
{"study_id": 197567, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus (T2DM) through a meta-analysis.", "results_summary": "Silymarin supplementation reduced fasting blood sugar, hemoglobin A1C, insulin, low-density lipoprotein cholesterol, and malondialdehyde while increasing high-density lipoprotein cholesterol levels, but had no significant effect on total cholesterol or triglycerides.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:42.073684+00:00"}
{"study_id": 48215, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential radiosensitization effects of silymarin/silibinin during cancer radiation exposure/radiotherapy.", "results_summary": "Silymarin/silibinin synergistically increased ionizing radiation-induced cytotoxicity in cancer cells, reduced tumor volume, weight, and growth in mice, and enhanced biochemical and histopathological changes in tumoral cells/tissues.", "population_specificity": "Cancer cells and tumor-bearing mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:43.392974+00:00"}
{"study_id": 197568, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of silymarin supplementation on glycemic indices and serum lipid profile in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "Silymarin supplementation significantly reduced fasting blood sugar, serum insulin, insulin resistance, triglycerides, and improved HDL cholesterol levels in T2DM patients compared to placebo. It also lowered total cholesterol and LDL cholesterol levels from baseline.", "population_specificity": "40 T2DM patients (20 male, 20 female), aged 25-50 years, on stable medication.", "effective_dosage": "140 mg of silymarin, thrice daily.", "study_duration": "45 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:43.541113+00:00"}
{"study_id": 197569, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Silymarin and/or vitamin E on oxidative stress markers and hemoglobin levels in hemodialysis patients.", "results_summary": "The combination of Silymarin and vitamin E reduced malondialdehyde (MDA) levels, increased red blood cell glutathione peroxidase (GPX) levels, and improved hemoglobin levels compared to controls. The effects were more pronounced with the combination therapy than with either supplement alone.", "population_specificity": "Patients on hemodialysis with end-stage renal disease.", "effective_dosage": "Silymarin 140 mg 3 times daily; vitamin E 400 IU/day.", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:45.840463+00:00"}
{"study_id": 37637, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of an educational intervention on the implementation of skin-to-skin care (SSC) in the NICU, focusing on SSC time, frequency, and early adoption.", "results_summary": "The study found that after the educational intervention, the prevalence of infants receiving SSC within their first 24 hours, the number of daily SSC sessions, and the duration of each session increased, with effects lasting over 2 years.", "population_specificity": "Neonatal intensive care unit (NICU) infants and their parents.", "effective_dosage": "Not specified", "study_duration": "Effects were observed over 2 years post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:46.938667+00:00"}
{"study_id": 48221, "supplement_id": 1557, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess silymarin's role in reducing liver inflammation and oxidative stress induced by carbon tetrachloride (CCl4) in rats.", "results_summary": "Silymarin reduced liver inflammation by countering oxidative stress and lowering inflammatory cytokine production (NF-\u03baB, TNF-\u03b1, IL-6, COX-2, TGF-\u03b2), as confirmed by histopathology.", "population_specificity": "Male Wistar rats (130 \u00b1 10 g weight).", "effective_dosage": "Not specified (administered orally for 4-12 weeks).", "study_duration": "4-12 weeks (varies by group).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:49.304335+00:00"}
{"study_id": 37638, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between inpatient skin-to-skin care rates and neurodevelopmental outcomes at 12 months in very preterm infants.", "results_summary": "Higher rates of skin-to-skin care were positively associated with improved neurodevelopmental scores at 12 months, accounting for 6.2% unique variance after adjusting for confounders. A 20-minute daily increase in skin-to-skin care was linked to a 10-point improvement in neurodevelopmental outcomes.", "population_specificity": "Very preterm infants (<32 weeks gestational age at birth).", "effective_dosage": "Approximately 17 minutes/day (averaging 2 days/week, 70 minutes/session).", "study_duration": "Duration of hospital stay (specific length not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:49.311581+00:00"}
{"study_id": 37639, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether implementing a dedicated neonatal assessment nurse (NAN) role could improve rates of immediate skin-to-skin care (SSC) and exclusive breastfeeding during the postpartum hospital stay.", "results_summary": "The study found that the NAN role significantly increased SSC rates (from 49% to 82% after vaginal birth and from 33% to 63% after cesarean birth) and exclusive breastfeeding rates at discharge (from 50% to 86%). Nurses demonstrated improved knowledge and met competency criteria for the new role.", "population_specificity": "Registered nurses and newborns in a tertiary care teaching hospital in the southeastern United States.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:49.592289+00:00"}
{"study_id": 37640, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of immediate skin-to-skin care (SSC) versus swaddling in reducing pain response to intramuscular vitamin K injection in neonates.", "results_summary": "SSC significantly reduced pain scores (NIPS) at 2 minutes post-injection compared to swaddling, with fewer newborns in the SSC group showing high pain scores. SSC also lowered pain scores below baseline, while swaddling resulted in higher pain scores than baseline.", "population_specificity": "Healthy full-term newborns delivered vaginally.", "effective_dosage": "Not applicable (intervention was SSC or swaddling, not a dosage-based treatment).", "study_duration": "Immediate intervention at 30 minutes post-birth, with pain assessment up to 2 minutes post-injection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:51.935993+00:00"}
{"study_id": 37641, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the feasibility and acceptability of teaching mindfulness during Kangaroo Care (KC) for mothers of premature babies in the NICU and to assess its effects on maternal stress, anxiety, depression, and mindful awareness.", "results_summary": "The study found that mothers practicing mindfulness during KC (MKC) showed significant reductions in anxiety, depression, and stress, along with increased mindful awareness (curiosity and decentering). The intervention was deemed acceptable and feasible by most participants.", "population_specificity": "Mothers of premature babies admitted to the NICU with an expected stay of at least four weeks.", "effective_dosage": "Two mindfulness exercises practiced during KC (specific frequency not detailed).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:53.317736+00:00"}
{"study_id": 37642, "supplement_id": 1558, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether early polyethylene bag use combined with skin-to-skin care reduces hypothermia in term-born infants compared to skin-to-skin care alone in resource-limited settings.", "results_summary": "The study found that skin-to-skin care with polyethylene bags significantly reduced moderate-severe hypothermia at 1 hour (34.6% vs. 47.4%) compared to skin-to-skin care alone, with no significant differences in severe hypothermia, hyperthermia, or adverse events between groups.", "population_specificity": "Term-born infants in a tertiary referral center in Lusaka, Zambia.", "effective_dosage": "Not specified (intervention involved polyethylene bag use with skin-to-skin care).", "study_duration": "Until discharge or 24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:53.660923+00:00"}
{"study_id": 37643, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the experiences of mothers using skin-to-skin care (SSC) for infants with neonatal abstinence syndrome (NAS), including perceived barriers and benefits.", "results_summary": "SSC was described as beneficial for bonding and healing, though mothers reported challenges such as emotional stress and hospital-related barriers. Four key themes emerged, highlighting both the positive impact and difficulties of SSC for this population.", "population_specificity": "Postpartum mothers of infants with neonatal abstinence syndrome (NAS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:53.807867+00:00"}
{"study_id": 37644, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether early skin-to-skin care (SSC) intervention (\u226416 days of life) compared to later SSC (>16 days of life) increased the likelihood of extremely low birth weight (ELBW) infants receiving mother's own milk (MOM) at discharge.", "results_summary": "Early SSC intervention increased from 46% to 73% among ELBW infants during the study period, and frequency of SSC was associated with higher rates of MOM at discharge (p < .05). ELBW infants in the early SSC group received more MOM at discharge compared to those in the later SSC group.", "population_specificity": "Extremely low birth weight (ELBW) infants.", "effective_dosage": "Not specified", "study_duration": "Intervention timing was \u226416 days of life vs. >16 days of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:57.203718+00:00"}
{"study_id": 37646, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of skin-to-skin care (SSC) on maternal stress (anxiety and cortisol levels) and attachment (attachment scores and oxytocin levels) before and after neonatal cardiac surgery.", "results_summary": "SSC significantly reduced maternal anxiety and salivary cortisol levels while increasing self-reported attachment scores, though no significant changes in oxytocin were observed.", "population_specificity": "Thirty mothers of infants hospitalized for neonatal cardiac surgery at a large children's hospital.", "effective_dosage": "Not specified", "study_duration": "Two time points (before and after surgery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:57.805928+00:00"}
{"study_id": 37645, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of combining music therapy with skin-to-skin care (SSC) on regional cerebral oxygenation (rSO2) and physiological stability in premature infants.", "results_summary": "The study found a modest but significant increase in rSO2 during SSC with music therapy and post-intervention phases, along with reduced variability in rSO2 and SpO2, suggesting short-term benefits. No significant changes were observed in heart rate, SpO2, or cFTOE.", "population_specificity": "Preterm infants in a tertiary neonatal intensive care unit.", "effective_dosage": "30 minutes of quiet SSC, 20 minutes of SSC with live maternal singing and guitar music, followed by another 30 minutes of quiet SSC.", "study_duration": "Total intervention lasted 80 minutes (30 + 20 + 30).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:59.193987+00:00"}
{"study_id": 37648, "supplement_id": 1558, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to increase the frequency of skin-to-skin care, parental holds, and parent touch events for infants in a cardiac and surgical neonatal intensive care unit, particularly when traditional SSC was not feasible.", "results_summary": "The study found an increased frequency of SSC and a variety of holds or alternative parent touch events post-intervention. Staff surveys supported the practice but identified persistent barriers.", "population_specificity": "Term and preterm infants in a cardiac and surgical neonatal intensive care unit.", "effective_dosage": "Not Assessed", "study_duration": "18 months post-intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:59.871896+00:00"}
{"study_id": 37647, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine the effect of skin-to-skin care on stress, pain, behavioral organization, and physiologic stability in infants with critical congenital heart disease before and after neonatal cardiac surgery.", "results_summary": "Skin-to-skin care significantly reduced pain scores and promoted calmer behavior states in infants at both preoperative and postoperative stages. It also improved physiologic stability (reduced heart and respiratory rates, increased systolic blood pressure) preoperatively, while cortisol levels remained stable during care but increased afterward, particularly in infants with higher baseline cortisol.", "population_specificity": "30 infants admitted preoperatively for critical congenital heart disease in a cardiac ICU and step-down unit.", "effective_dosage": "1 hour of skin-to-skin care with biological mothers once preoperatively (T1) and once postoperatively (T2).", "study_duration": "Two sessions (preoperative and postoperative), each lasting 1 hour.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:23:59.961305+00:00"}
{"study_id": 37649, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to understand women's experiences, concerns, and expectations regarding skin-to-skin care during cesarean birth.", "results_summary": "The study found that women highly valued their skin-to-skin care experience post-cesarean birth, reinforcing the importance of advocating for and implementing this practice whenever possible. Themes highlighted the significance of the intervention in their overall birth experience.", "population_specificity": "Women who had skin-to-skin care post-cesarean birth within the last 10 years (N = 13).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:01.527993+00:00"}
{"study_id": 37651, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the acceptability of reducing light and noise levels during skin-to-skin care (SSC) in the NICU among nurses and whether it interfered with care delivery.", "results_summary": "Most nurses found reducing light and noise levels during SSC acceptable, reported no interference with care delivery, and approved of nine specific interventions for reducing these levels. The findings support further research via a full-scale RCT to evaluate the intervention's impact on preterm infants and mothers' well-being.", "population_specificity": "Neonatal nurses from a level III NICU and preterm infants/mothers undergoing SSC.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:02.497232+00:00"}
{"study_id": 37650, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility, safety, and outcomes of immediate and uninterrupted skin-to-skin care (SSC) during cesarean surgery, focusing on maternal/newborn physiologic stability, stress, comfort, satisfaction, and exclusive breast milk feeding rates.", "results_summary": "Immediate SSC during cesarean surgery was feasible and safe, with no negative effects on maternal or newborn physiologic stability. Women who received SSC during surgery reported higher satisfaction and lower stress (measured by salivary cortisol), though exclusive breast milk feeding rates at discharge did not differ between groups.", "population_specificity": "Women undergoing medically uncomplicated cesarean surgery and their newborns (n=40 total, 20 per group).", "effective_dosage": "SSC began either immediately after birth (Group 1, average 0.89 minutes) or post-surgery (Group 2, average 46 minutes), lasting an average of 300 minutes and 126 minutes, respectively.", "study_duration": "SSC continued uninterrupted for approximately 5 hours in Group 1 and 2 hours in Group 2.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:05.688659+00:00"}
{"study_id": 37653, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether skin-to-skin care (SSC) improves short-term physiologic stress outcomes in premature infants in the NICU compared to incubator care.", "results_summary": "The study found that SSC improves short-term cardiorespiratory stress outcomes and strongly reduces cortisol while increasing oxytocin levels in preterm infants, though some mixed findings were noted. The evidence supports SSC as a beneficial intervention for stress reduction in the NICU.", "population_specificity": "Premature infants in the neonatal intensive care unit (NICU).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:06.189850+00:00"}
{"study_id": 37652, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether skin-to-skin care reduces postpartum depression (PPD) among mothers of preterm or low birthweight infants.", "results_summary": "The meta-analysis found a small but statistically significant reduction (1.04%) in standardized depression scores with skin-to-skin care compared to standard care, though clinical relevance was minimal and heterogeneity among studies was high.", "population_specificity": "Mothers of preterm or low birthweight infants in neonatal intensive care units (NICUs).", "effective_dosage": "Sessions ranged from 15 minutes to 1 hour, with frequency from thrice daily to thrice weekly.", "study_duration": "Intervention duration varied from one week to over two months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:06.526673+00:00"}
{"study_id": 37654, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to describe the physiologic stress mechanisms in NICU infants and how skin-to-skin care (SSC) mitigates these stress responses.", "results_summary": "SSC was found to be a safe and effective intervention for reducing stress in NICU infants and their parents, supported by current literature. Barriers and facilitators to its implementation were also reviewed.", "population_specificity": "Critically ill infants in the NICU and their parents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:06.724535+00:00"}
{"study_id": 37658, "supplement_id": 1558, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "To investigate the feasibility and safety of skin-to-skin care after birth for moderately preterm infants.", "results_summary": "The study found no significant differences in body temperature or blood glucose levels between preterm infants receiving skin-to-skin care and those receiving conventional incubator treatment, suggesting skin-to-skin care may be feasible and safe.", "population_specificity": "Preterm infants born vaginally with gestational ages of 32 weeks/0 days to 34 weeks/6 days.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:09.486212+00:00"}
{"study_id": 37656, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of prolonged skin-to-skin care (SSC) during blood glucose monitoring in late preterm and term infants at-risk for neonatal hypoglycemia.", "results_summary": "The study found that SSC significantly reduced hypoglycemia admissions to the neonatal intensive care unit (from 8.1% to 3.5%) and decreased intravenous dextrose bolus administration (from 5.9% to 2.1%). Exclusive breastfeeding rates increased but were not statistically significant.", "population_specificity": "Late preterm and term infants at-risk for neonatal hypoglycemia.", "effective_dosage": "Prolonged SSC during blood glucose monitoring (12-24 hours).", "study_duration": "1 year pre- and post-intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:09.558390+00:00"}
{"study_id": 37657, "supplement_id": 1558, "safety_score": "100", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of skin-to-skin care (SSC) on procedural pain in neonates compared to no intervention, sucrose, or other analgesics, and to assess the safety and optimal administration methods of SSC.", "results_summary": "SSC was effective in reducing pain indicators such as heart rate and crying time, particularly during heel lance and intramuscular injection procedures. No adverse events were reported, and SSC was found to be safe for single painful procedures.", "population_specificity": "Term infants (\u226537 weeks' postmenstrual age) and preterm infants (<37 weeks' postmenstrual age).", "effective_dosage": "Not specified (varied by study).", "study_duration": "Duration of SSC varied by study (specifics not provided).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:09.831662+00:00"}
{"study_id": 37659, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cost-effectiveness and clinical benefits of an intervention (\"Getting It Right From the Start\") designed to increase breastfeeding and kangaroo skin-to-skin care rates in neonatal units.", "results_summary": "The intervention demonstrated significant cost savings, with every \u00a31 invested generating \u00a34.00 to \u00a313.82 in benefits, primarily from increased skin-to-skin care and breastfeeding. The greatest savings were linked to reductions in gastroenteritis and necrotising enterocolitis cases.", "population_specificity": "Neonatal units in two Neonatal Networks in the UK (18 units total).", "effective_dosage": "Not specified", "study_duration": "2011-12 (approximately 1 year)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:12.067193+00:00"}
{"study_id": 37660, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to synthesize and interpret qualitative findings on parental experiences of skin-to-skin care (SSC) for newborn infants.", "results_summary": "SSC was found to be both restorative and energy-draining for parents, with a supportive environment facilitating positive experiences. Positive experiences enhanced parental self-esteem and readiness to assume full responsibility for their child.", "population_specificity": "401 mothers and 94 fathers from 9 countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:13.011923+00:00"}
{"study_id": 37663, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to understand the acceptance and barriers to skin-to-skin care (STSC) in a rural African community and inform a behavior-based health intervention.", "results_summary": "The study found significant barriers to STSC, including postpartum pain and fear of harming the umbilicus, with no participants practicing it continuously. Despite challenges, STSC promotion was deemed vital for newborn survival in low-resource settings.", "population_specificity": "Predominantly rural, agrarian communities in Kintampo, Ghana, with diverse ethnic groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:15.209120+00:00"}
{"study_id": 37661, "supplement_id": 1558, "safety_score": "95", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness and safety of Skin-to-skin care (SSC) for pain control in neonates undergoing painful procedures, comparing it to no intervention, sucrose, or other analgesics, and examining factors like duration and provider of SSC.", "results_summary": "SSC was found effective for pain relief during procedures like heel lance, as measured by composite pain indicators, with no reported adverse events. Physiological indicators showed no significant differences, while behavioural indicators favoured SSC, though with potential bias.", "population_specificity": "Term infants (>37 weeks postmenstrual age) and preterm infants (<37 weeks postmenstrual age).", "effective_dosage": "Not specified (varied by study).", "study_duration": "Duration varied by study (specifics not provided).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:15.827799+00:00"}
{"study_id": 37662, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether home visits promoting skin-to-skin care (SSC) increased its adoption, especially among low birthweight babies in rural Ghana.", "results_summary": "The intervention significantly increased SSC adoption (19.4% higher in Newhints zones) and doubled SSC for more than 2 hours (7.5% vs. control), with greater effects for LBW babies. However, overall SSC duration remained low.", "population_specificity": "Live births in seven rural districts of Brong Ahafo Region, Ghana, including 10.1% low birthweight babies.", "effective_dosage": "Not specified", "study_duration": "November 2008 to December 2009 (approximately 13 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:16.283944+00:00"}
{"study_id": 37664, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate infant thermal balance and the physical environment in extremely preterm infants during skin-to-skin care (SSC).", "results_summary": "Infants maintained normal body temperature during SSC, though skin temperature dropped during transfer but increased during SSC. Ambient humidity and temperature were lower during SSC, and insensible water loss through the skin was higher, but the increased loss was small and did not affect fluid balance.", "population_specificity": "Extremely preterm infants (gestational age 22-26 weeks; postnatal age, 2-9 days).", "effective_dosage": "Not Assessed", "study_duration": "Measurements were taken during pretest (in incubator), test (during SSC), and posttest (in incubator) periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:18.497919+00:00"}
{"study_id": 37666, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to explore the experiences of healthy mothers practicing skin-to-skin care with their healthy, full-term infants in the first days after birth.", "results_summary": "The study found that skin-to-skin care initiated a positive spiral of mutual interaction, enhancing mother-infant affinity and promoting happiness, peace, and satisfaction in newborns, even those who were initially crying or troublesome.", "population_specificity": "Healthy mothers of healthy, full-term infants who had childbirth in a hospital setting.", "effective_dosage": "Not specified", "study_duration": "First days after birth (interviews conducted 1-2 weeks post-birth)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:18.634891+00:00"}
{"study_id": 37665, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to improve skin-to-skin care and exclusive breastfeeding rates at hospital discharge using a quality improvement pilot study and electronic health record review.", "results_summary": "The study found a significant 25% improvement in skin-to-skin care rates post-intervention, particularly among cesarean section patients, but no significant change in exclusive breastfeeding rates. Babies completing all nine instinctive stages during skin-to-skin care were more likely to exclusively breastfeed.", "population_specificity": "Mothers and newborns in a U.S. hospital setting, including cesarean section patients.", "effective_dosage": "Not specified", "study_duration": "5-day pilot study (Part 1); post-intervention data collected over 5 months (Part 2)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:18.726662+00:00"}
{"study_id": 37667, "supplement_id": 1558, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the acceptability and effectiveness of skin-to-skin care (STSC) in preventing newborn hypothermia and its cultural integration in rural Uttar Pradesh, India.", "results_summary": "STSC was highly accepted and perceived to prevent newborn hypothermia, enhance maternal bonding, and protect against cultural beliefs. Hypothermia incidence was high, but STSC showed potential benefits without reported adverse events.", "population_specificity": "Rural mothers and newborns in Uttar Pradesh, India, including low birth weight (LBW) and normal birth weight (NBW) infants.", "effective_dosage": "Not specified", "study_duration": "Measurements taken on day of life 0 or 1.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:21.538136+00:00"}
{"study_id": 37668, "supplement_id": 1558, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of early skin-to-skin contact between mothers and their healthy full-term babies on breastfeeding initiation, duration, and maternal satisfaction.", "results_summary": "Skin-to-skin care showed a non-significant increase in successful first breastfeeding (91% vs. 83%) and breastfeeding rates at 4 months (43% vs. 40%). Mothers in the skin-to-skin group reported higher satisfaction (90% vs. 59%) and preference for future use (86% vs. 30%), and babies had slightly higher body temperatures post-birth.", "population_specificity": "Healthy full-term babies and their mothers in a UK hospital setting.", "effective_dosage": "Not specified", "study_duration": "Immediate post-delivery intervention, with follow-up at 4 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:22.584789+00:00"}
{"study_id": 37670, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the type and duration of mother-infant contact (skin-to-skin vs. wrapped holding) in preterm newborns (32-37 weeks gestation) receiving kangaroo care versus standard care.", "results_summary": "Skin-to-skin contact was lower than expected (22.0% postpartum, 7.5% NICU for KC dyads), but total contact time (skin-to-skin plus wrapped holding) for KC dyads was more than double that of controls. Hospital and social barriers limited skin-to-skin implementation.", "population_specificity": "Preterm infants (32 to <37 weeks gestation) and their mothers.", "effective_dosage": "Not specified", "study_duration": "0-48 hours postbirth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:24.773939+00:00"}
{"study_id": 37671, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the effectiveness of Kangaroo care (KC) for adolescent parents of preterm twins and identify different KC methods for twins.", "results_summary": "The study found that KC helped adolescent parents interact with, respond to, and take responsibility for their preterm twins, suggesting it was an effective intervention. Three KC methods for twins were identified: separate, sequential, and shared.", "population_specificity": "Adolescent parents of 32-week preterm twin sons.", "effective_dosage": "Not specified", "study_duration": "Began 19 hours postbirth (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:24.832485+00:00"}
{"study_id": 37669, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to examine the feasibility of implementing kangaroo care (skin-to-skin care) at the beginning of colicky episodes in infants.", "results_summary": "The study found that conducting the intervention via the internet was not feasible due to a high dropout rate (only 2 out of 75 participants completed all parts). Kangaroo care was suggested as a promising intervention, but the study lacked sufficient data to evaluate its efficacy.", "population_specificity": "Mothers of colicky infants.", "effective_dosage": "Not specified", "study_duration": "2 weeks of kangaroo care intervention, followed by 2 days without it.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:24.842178+00:00"}
{"study_id": 50174, "supplement_id": 1559, "safety_score": "100", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sleep hygiene education improves sleep quality and reduces fatigue in patients with OSAS (Obstructive Sleep Apnea Syndrome) and atrial fibrillation.", "results_summary": "Sleep hygiene education showed no significant improvement in sleep quality subscales but reduced fatigue, concentration, motivation, and physical activity scores in the intervention group after one month. It positively affected sleep duration but was ineffective in ensuring high-quality sleep.", "population_specificity": "Patients with atrial fibrillation receiving inpatient treatment in a cardiology service.", "effective_dosage": "Not Assessed", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:26.658980+00:00"}
{"study_id": 50176, "supplement_id": 1559, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of a sleep hygiene training program on sleep quality in hemodialysis patients.", "results_summary": "The sleep hygiene program significantly improved global sleep quality and specific components (subjective sleep quality, sleep latency, sleep disturbances, and daytime dysfunction) in the intervention group compared to the control group.", "population_specificity": "Hemodialysis patients", "effective_dosage": "6 sessions over 1 month", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:27.442994+00:00"}
{"study_id": 37672, "supplement_id": 1558, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore parents' perceptions of skin-to-skin care with preterm infants on assisted ventilation and identify factors influencing their decision to continue or discontinue the practice.", "results_summary": "The study found that parents experienced ambivalence (yearning to hold their infant but feeling apprehensive), emphasized the need for a supportive environment, and valued the special quality of parent-infant interaction. Differences in narratives highlighted the importance of individualized care, with some parents resuming skin-to-skin care at home after discontinuing it in the hospital.", "population_specificity": "Preterm infants on assisted ventilation and their parents (eight mothers and one father).", "effective_dosage": "Two 60-minute skin-to-skin care sessions.", "study_duration": "Not specified beyond the two sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:28.406507+00:00"}
{"study_id": 37557, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the delivery and effectiveness of Sleep Restriction Therapy (SRT) by primary care nurses compared to a sleep hygiene booklet alone for adults with insomnia disorder.", "results_summary": "SRT was successfully delivered by practice nurses and generally well-received, with improvements in sleep efficiency for participants who engaged positively, while those who struggled with adherence or had negative attitudes did not show benefits. Challenges included treatment complexity, patient difficulties maintaining SRT, and contextual barriers like nurse time constraints.", "population_specificity": "Adults with insomnia disorder in a general practice setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:30.176991+00:00"}
{"study_id": 37558, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the dynamics of cumulative neurobehavioural impairment caused by chronic sleep restriction and the impact of a 1-day dose-response intervention sleep opportunity.", "results_summary": "The study found that neurobehavioural impairment accumulated across two 5-day periods of sleep restriction, with minimal and short-lived effects from a 1-day intervention sleep opportunity. Long-term sleep-wake history dominated subsequent neurobehavioural functioning regardless of the intervention.", "population_specificity": "70 healthy adults", "effective_dosage": "Sleep restriction to 4 hours per day, with intervention sleep doses ranging from 0 to 12 hours", "study_duration": "Two 5-day periods of sleep restriction separated by a 1-day intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:31.379870+00:00"}
{"study_id": 37559, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sleep restriction during abstinence from oxycodone self-administration would increase drug seeking behavior in rats.", "results_summary": "Sleep restriction during abstinence did not significantly affect oxycodone seeking in extinction or footshock reinstatement tests. Some behavioral phenotypes were associated with drug seeking, but these varied by sex and assessment type.", "population_specificity": "Male and female rats undergoing oxycodone self-administration and abstinence.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:32.966933+00:00"}
{"study_id": 37562, "supplement_id": 1560, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether exercise could mitigate the negative effects of sleep restriction on mood state and alertness.", "results_summary": "Sleep restriction significantly worsened mood, wellness, and alertness, and exercise did not mitigate these effects. Both sleep-restricted groups showed increased fatigue and slower reaction times compared to the normal sleep group.", "population_specificity": "24 healthy young males", "effective_dosage": "Sleep restriction (TST = 230 \u00b1 5 min or 235 \u00b1 5 min with exercise)", "study_duration": "5 nights", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:33.814336+00:00"}
{"study_id": 37561, "supplement_id": 1560, "safety_score": "90", "efficacy_score": 85, "quality_score": 92, "study_goal": "The researchers aimed to assess the clinical and cost-effectiveness of nurse-delivered sleep restriction therapy compared to sleep hygiene for treating insomnia disorder in primary care.", "results_summary": "Sleep restriction therapy significantly reduced insomnia severity at 6 months compared to sleep hygiene (mean ISI score 10.9 vs. 13.9, p<0.0001) and was likely cost-effective with an incremental cost per QALY gained of \u00a32076. Serious adverse events were rare and unrelated to the intervention.", "population_specificity": "Adults with insomnia disorder (mean age 55.4, 76.2% female) recruited from general practices in England.", "effective_dosage": "Four sessions of nurse-delivered sleep restriction therapy plus a sleep hygiene booklet.", "study_duration": "Outcomes assessed at 3, 6, and 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:35.082103+00:00"}
{"study_id": 37560, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sleep restriction therapy reduces rapid eye movement (REM) sleep fragmentation compared to a control intervention in individuals with insomnia.", "results_summary": "The study found no significant group differences in the primary REM fragmentation index at week 1 or week 4. However, secondary indices showed small-to-medium reductions in REM fragmentation in the sleep restriction group at week 1, but not at week 4. No effects were observed for non-REM sleep fragmentation.", "population_specificity": "56 participants (39 female, mean age 40.78 \u00b1 9.08 years) with insomnia.", "effective_dosage": "Not specified (sleep restriction therapy vs. time in bed regularisation).", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:35.696655+00:00"}
{"study_id": 37563, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to systematically evaluate different measures of adherence to cognitive behavioural therapy for insomnia (CBT-I) involving sleep restriction and their relationship with treatment outcomes.", "results_summary": "The study found that none of the adherence measures predicted insomnia severity, and baseline factors like dysfunctional thoughts, depression, or perfectionism did not predict adherence. Most patients benefited from treatment, but the small sample size and limited variance in outcomes may explain the lack of significant findings.", "population_specificity": "23 patients diagnosed with insomnia according to DSM-5 criteria.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:36.017677+00:00"}
{"study_id": 37564, "supplement_id": 1560, "safety_score": "40", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of sleep fragmentation and partial sleep restriction on cardiac autonomic tone using heart rate variability (HRV) parameters.", "results_summary": "Sleep restriction significantly increased heart rate and decreased HRV parameters, indicating heightened sympathetic tone and reduced vagal tone, while sleep fragmentation showed no significant effects on cardiac autonomic modulation. Recovery effects were observed for some HRV parameters after sleep restriction.", "population_specificity": "Twenty male subjects, aged 40.6 \u00b1 7.5 years.", "effective_dosage": "5 hours of sleep per night (sleep restriction) or awakenings every hour (sleep fragmentation).", "study_duration": "2 weeks, with one intervention night per week.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:37.357237+00:00"}
{"study_id": 37566, "supplement_id": 1560, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of sleep restriction therapy and sleep compression therapy on objective sleep measures, focusing on the magnitude and timing of these effects.", "results_summary": "Sleep restriction initially reduced total sleep time compared to sleep compression, but both treatments improved sleep continuity, with earlier improvements in sleep restriction. No substantial differences were found between the two treatments after 10 weeks.", "population_specificity": "36 participants with insomnia from a larger study.", "effective_dosage": "Not specified", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:39.546726+00:00"}
{"study_id": 37565, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the impact of chronic sleep restriction (CSR) on the IGF-1 signaling pathway and its role in modulating amyloid-\u03b2 (A\u03b2) peptide metabolism and cortical deposition.", "results_summary": "CSR decreased circulating IGF-1 levels in mice and increased A\u03b2 accumulation in the frontal cortex, along with elevated BACE-1 and C99 expressions. Down-regulating IGF-1R reduced A\u03b2 deposition by inhibiting BACE-1 activity, independent of body weight changes.", "population_specificity": "8-week-old IGF-1R+/- and wild-type C57BL/6 mice.", "effective_dosage": "Not specified (CSR induced via slowly rotating drum).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:39.874091+00:00"}
{"study_id": 37568, "supplement_id": 1560, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to explore whether armodafinil, a wakefulness promoter, could enhance the effectiveness of sleep restriction therapy (SRT) for insomnia disorder by mitigating its daytime side effects.", "results_summary": "SRT alone showed a robust clinical response in reducing insomnia severity, but adding armodafinil did not provide additional benefits and was statistically inferior to historical controls. The combination was associated with frequent minor side effects but was generally safe and acceptable.", "population_specificity": "Insomnia patients (25 in the trial, 33 historical controls).", "effective_dosage": "150 mg/day of armodafinil.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:42.895552+00:00"}
{"study_id": 37569, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine how sleep restriction affects skeletal muscle transcriptome related to glucose metabolism and whether exercise could mitigate these effects.", "results_summary": "Sleep restriction increased inflammatory and immune response pathways in skeletal muscle, while exercise attenuated these changes. No significant individual gene-level changes were observed, but exercise reversed some transcriptional alterations seen with sleep deprivation.", "population_specificity": "20 healthy young males", "effective_dosage": "Sleep restriction (4 hours time in bed per night) with or without three high-intensity interval exercise sessions", "study_duration": "Five nights", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:43.123741+00:00"}
{"study_id": 37570, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how chronic sleep restriction affects the circadian rhythm of clock genes and downstream output signals in mice.", "results_summary": "Sleep restriction disrupted the circadian rhythm of clock genes (e.g., Cry1, Per1/2/3) and altered the acrophase of others (e.g., Bmal1, Clock). It also affected upstream signals (ERK, EIFs) and downstream plasma output signals (melatonin, corticosterone, IL-6, TNF-\u03b1), indicating circadian dysfunction.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:44.283045+00:00"}
{"study_id": 37567, "supplement_id": 1560, "safety_score": "40", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of short-term sleep restriction followed by recovery on subjective health status, inflammation, and lipid metabolism in individuals with and without cold hypersensitivity (CH).", "results_summary": "Short-term sleep restriction led to increased stress, impaired quality of life (QOL), and decreased LDL-C levels, with more pronounced effects in the CH group. The study suggests that CH status may influence clinical risks associated with insufficient sleep.", "population_specificity": "118 healthy adults aged 35-44 years without pre-existing sleep disturbances.", "effective_dosage": "4-hour sleep restriction per day for 3 days.", "study_duration": "3 days of sleep restriction followed by 4 days of recovery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:44.986150+00:00"}
{"study_id": 37571, "supplement_id": 1560, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and mechanisms of sleep restriction therapies (sleep restriction therapy and bedtime restriction therapy) as standalone interventions for chronic insomnia in middle childhood, including effects on anxiety, cognitive performance, and parasomnias.", "results_summary": "Both sleep restriction groups showed significant reductions in total sleep time and increases in evening sleepiness during treatment, with maintained improvements in insomnia at follow-up. Anxiety and worry improved across all groups, but no differences were found between restriction and control groups; no adverse effects on cognitive functioning or parasomnias were observed.", "population_specificity": "61 children aged 6-14 years (mean 9.1 years, 54% female) with chronic insomnia disorder.", "effective_dosage": "Two weekly 60-minute treatment sessions with a psychologist.", "study_duration": "2-week treatment period with follow-up at 4 weeks post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:46.307992+00:00"}
{"study_id": 37572, "supplement_id": 1560, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplemental protein and multinutrient supplementation improved wound healing markers after acute stress induced by 72-hour sleep restriction.", "results_summary": "The study found that skin barrier restoration was significantly faster with the multinutrient supplement (NUT) compared to placebo (PLA). However, no treatment effects were observed on cytokine levels from wound fluid.", "population_specificity": "Generally healthy young adults (18 males, 2 females; mean age 19.7 \u00b1 2.30 years).", "effective_dosage": "1.50 g \u00b7 kg-1 \u00b7 d-1 protein plus multinutrient beverage (l-arginine: 20.0 g/d; l-glutamine: 30.0 g/d; omega-3 fatty acids: 1.00 g/d; zinc sulfate: 24.0 mg/d; cholecalciferol: 800 IU/d; vitamin C: 400 mg/d).", "study_duration": "During 72-hour sleep restriction and for 4 days afterward.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:50.130941+00:00"}
{"study_id": 37573, "supplement_id": 1560, "safety_score": "40", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the impact of chronic sleep restriction (CSR) on sleep continuity and structure in healthy individuals with satiated sleep needs, as well as its effects on neurobehavioral performance.", "results_summary": "CSR reduced sleep duration by ~95 minutes per night, increased Slow-Wave Activity, and consolidated sleep, but sustained vigilant attention did not fully recover even after nine nights of recovery. Traditional sleep quality metrics improved, but neurobehavioral performance deteriorated.", "population_specificity": "Nine healthy participants with satiated sleep needs.", "effective_dosage": "5/5.6-hour time-in-bed per night during CSR.", "study_duration": "21 nights of CSR, preceded by 4 nights of sleep extension and followed by 9 nights of recovery sleep.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:50.647034+00:00"}
{"study_id": 97688, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of sulforaphane and other bioactive dietary compounds on human breast cancer cell lines and explore their potential therapeutic mechanisms.", "results_summary": "The study found that sulforaphane modulates epigenetic mechanisms such as DNA methylation and histone modifications, potentially reversing molecular alterations in cancer cells. These effects suggest therapeutic potential for breast cancer treatment.", "population_specificity": "Human breast cancer cell lines (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:57.722598+00:00"}
{"study_id": 97685, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the cardioprotective potential of sulforaphane and other phytochemicals by modulating sirtuin-mediated deacetylation in cardiovascular diseases.", "results_summary": "The study suggests sulforaphane has cardioprotective effects, likely through modulation of protein acetylation levels, similar to other sirtuin activators and phytochemicals. However, specific results for sulforaphane are not detailed in the abstract.", "population_specificity": "Not specified (general cardiovascular disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:58.523985+00:00"}
{"study_id": 97686, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss the role of HDAC6 in physiological and cancerous conditions and explore the anticancer properties of natural-derived compounds, including Sulforaphane, through HDAC6 modulation.", "results_summary": "The abstract highlights HDAC6 as a potential therapeutic target in cancer and mentions the anticancer properties of natural-derived compounds, including Sulforaphane, via HDAC6-related pathways, but does not provide specific results for Sulforaphane.", "population_specificity": "Not specified (general discussion of HDAC6 in cancer and physiological conditions).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:58.751458+00:00"}
{"study_id": 97689, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the modulation of the Nrf2 pathway by natural compounds, including Sulforaphane, and its implications for anticancer strategies.", "results_summary": "The study found that Sulforaphane and other natural compounds can modulate the Nrf2 pathway, which may have anticancer effects, but Nrf2 activation in cancer cells could also lead to chemoresistance. The role of Nrf2 in cancer depends on tight control of its activity, tumor microenvironment, and cell type.", "population_specificity": "Not specified (general discussion of Nrf2 modulation in cancer)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:59.167616+00:00"}
{"study_id": 97683, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Sulforaphane, among other phytochemicals, as a chemopreventive agent and adjuvant therapy for Head and Neck Squamous Cell Carcinoma (HNSCC).", "results_summary": "Sulforaphane was found to inhibit HNSCC growth by regulating cancer cell proliferation, impeding cell cycle progression, inducing apoptosis, and preventing angiogenesis. It also showed potential to protect normal cells during treatment and reduce damage from chemotherapy and radiotherapy.", "population_specificity": "Patients at risk for or with developed Head and Neck Squamous Cell Carcinoma (HNSCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:24:59.626907+00:00"}
{"study_id": 97687, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the epigenetic modifications in melanoma and the potential role of bioactive phytochemicals, including Sulforaphane, in modulating these changes for skin cancer prevention and therapy.", "results_summary": "The abstract highlights that bioactive phytochemicals, such as Sulforaphane, exhibit epigenetic modulatory capabilities, which may influence genes involved in cell cycle, proliferation, motility, and apoptosis, suggesting potential chemopreventive and therapeutic effects against skin cancer.", "population_specificity": "Not specified (general discussion on melanoma and nonmelanoma skin cancers).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:02.822506+00:00"}
{"study_id": 97684, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the neuroprotective effects of sulforaphane (SFN) and its metabolite erucin (ERN) against oxidative stress in Parkinson's disease models.", "results_summary": "SFN showed superior neuroprotective effects compared to ERN in vitro, increasing Nrf2 protein, mRNA Nrf2, and total GSH levels, while both compounds exhibited similar effects when administered simultaneously with oxidative stress. These findings were confirmed in a mouse model of Parkinson's disease.", "population_specificity": "SH-SY5Y cells (in vitro) and a 6-OHDA-PD mouse model (in vivo).", "effective_dosage": "5 \u03bcM (in vitro).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:03.239884+00:00"}
{"study_id": 97690, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a high glucosinolate diet (leading to sulforaphane production) could influence osteoarthritis progression by analyzing synovial fluid and plasma biomarkers in knee osteoarthritis patients.", "results_summary": "The high glucosinolate diet resulted in detectable ITCs (including sulforaphane) in synovial fluid and plasma, with 125 differentially expressed proteins in synovial fluid, suggesting a biological effect. The study sets the stage for further clinical trials to assess functional outcomes.", "population_specificity": "40 patients with knee osteoarthritis undergoing total knee replacement.", "effective_dosage": "Not specified (high vs. low glucosinolate diet).", "study_duration": "14 days prior to surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:03.246188+00:00"}
{"study_id": 97691, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, bioavailability, and efficacy of sulforaphane as a chemopreventive agent for bladder cancer.", "results_summary": "Sulforaphane was found to be bioavailable both systemically and in the bladder, potent in inhibiting bladder cancer carcinogenesis through multiple mechanisms, and safe at the studied doses without toxicities. Epidemiological, in vitro, preclinical, and early-phase trial data support its potential as a chemopreventive agent.", "population_specificity": "Patients at risk for or with bladder cancer (early and late stages).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:06.528801+00:00"}
{"study_id": 97692, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore Sulforaphane's potential as an EZH2 inhibitor and its anti-cancer effects among other natural products.", "results_summary": "Sulforaphane was identified as an EZH2 modulator, potentially suppressing cancer through mechanisms like histone methylation inhibition and down-regulation of matrix metalloproteinase expression. The abstract suggests Sulforaphane may offer anti-cancer benefits with low cytotoxic effects.", "population_specificity": "Not specified (general cancer-related mechanisms discussed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:06.942352+00:00"}
{"study_id": 97693, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize current understanding of pancreatic cancer stem cells (CSCs) and evaluate natural compounds, including sulforaphane, for their potential to target these cells.", "results_summary": "The abstract suggests sulforaphane is among the phytochemicals that may inhibit pancreatic CSCs, potentially offering a novel approach for prevention and treatment, though specific results for sulforaphane are not detailed.", "population_specificity": "Pancreatic ductal adenocarcinoma (theoretical or preclinical focus, not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:07.939118+00:00"}
{"study_id": 97694, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the metabolic fate, biological effects, and potential health benefits of glucosinolate breakdown products, particularly sulforaphane, with a focus on anti-cancer effects and other diseases.", "results_summary": "Epidemiological and clinical evidence suggests sulforaphane has potential anti-cancer effects, supported by multiple molecular mechanisms such as modulation of inflammation, apoptosis, and epigenetic regulation. Ongoing clinical trials may further clarify its protective effects against cancer and other diseases.", "population_specificity": "General human population, with emphasis on epidemiological and clinical trial data.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:07.949204+00:00"}
{"study_id": 97695, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the potential chemopreventive and therapeutic effects of sulforaphane against cancer, focusing on its mechanisms and clinical relevance.", "results_summary": "Sulforaphane demonstrated multi-level anticancer activity, including DNA damage protection, cell cycle modulation, pro-apoptotic, anti-angiogenesis, and anti-metastasis effects, primarily via Nrf2 activation. Clinical data are limited but suggest promise as an adjuvant therapy.", "population_specificity": "Not specified (review of experimental and clinical data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:08.555500+00:00"}
{"study_id": 97698, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential therapeutic utility of sulforaphane in alleviating neuroinflammation and neurodegeneration associated with Alzheimer's disease.", "results_summary": "The study suggests sulforaphane may modulate neuroinflammation by targeting the NLRP3 inflammasome, potentially offering neuroprotective effects against Alzheimer's disease symptoms. However, specific clinical outcomes or direct efficacy data were not detailed in the abstract.", "population_specificity": "Not specified (general focus on Alzheimer's disease and neuroinflammation)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:11.433361+00:00"}
{"study_id": 97697, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to discuss experimental evidence pointing to mitochondrial dysfunction in cancer chemoprevention by promising phytochemicals, including sulforaphane.", "results_summary": "The abstract highlights that sulforaphane and other phytochemicals target mitochondria to induce cancer cell-selective death, suggesting potential efficacy in cancer chemoprevention. However, specific results on sulforaphane's effects are not detailed in the abstract.", "population_specificity": "Preclinical models (not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:11.649215+00:00"}
{"study_id": 97700, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of sulforaphane as a therapeutic intervention for autism spectrum disorders (ASD) by modulating cellular stress responses and heat shock protein expression.", "results_summary": "The study suggests sulforaphane may improve cognition and behavior in ASD by inducing metabolic effects similar to those seen during febrile illness, potentially offering neuroprotective benefits. However, the findings require cautious interpretation and further research.", "population_specificity": "Children with autism spectrum disorders (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:14.951306+00:00"}
{"study_id": 97702, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the potential of sulforaphane and other phytochemicals as therapeutic agents targeting breast cancer stem cells (CSCs) to control recurrence and metastasis.", "results_summary": "The abstract suggests sulforaphane may target breast CSCs and their signaling pathways, potentially serving as a novel therapeutic agent for breast cancer treatment and future drug development.", "population_specificity": "Breast cancer (specifically focusing on cancer stem cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:15.704880+00:00"}
{"study_id": 97699, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate sulforaphane's effects on AGE formation and RAGE-mediated signaling pathways in various cell types and organs, including endothelial cells, vessels, and heart.", "results_summary": "The study suggests sulforaphane may block the AGE-RAGE axis, potentially reducing oxidative stress, inflammation, and fibrosis, which could protect against cardiovascular disease. However, specific results for sulforaphane are summarized alongside other phytochemicals without detailed standalone data.", "population_specificity": "Various cell types and organs (endothelial cells, vessels, heart); no specific human population mentioned.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:15.770138+00:00"}
{"study_id": 97703, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane supplementation could induce antioxidant gene expression and protect against neutrophilic airway inflammation in healthy humans exposed to ozone.", "results_summary": "The study found that sulforaphane supplementation did not induce antioxidant gene expression or protect against neutrophilic airway inflammation in the ozone-exposure model, suggesting it is not a promising candidate for larger clinical trials targeting airway inflammation.", "population_specificity": "Healthy human subjects", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:16.460288+00:00"}
{"study_id": 97701, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the potential of sulforaphane, among other phytochemicals, in preventing colorectal cancer by exploring its underlying mechanisms.", "results_summary": "The study suggests sulforaphane exhibits strong antioxidant, anti-inflammatory, and anti-cancer effects by modulating specific signaling pathways and molecular markers, potentially inhibiting colorectal cancer development. However, clinical validation is needed to confirm these preventive effects.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no human population detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:16.776830+00:00"}
{"study_id": 97705, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Sulforaphane (SFN) as a potential HDAC inhibitor for treating pancreatic cancer and explore its molecular mechanisms and combinatorial therapeutic strategies.", "results_summary": "The study found that SFN exhibits cytotoxic effects in pancreatic cancer models by modulating histone and nonhistone proteins, inducing cell cycle arrest, differentiation, and apoptosis. It also highlights SFN's potential in combination therapies to overcome chemoresistance and reduce toxicity.", "population_specificity": "Pancreatic cancer models (in vitro or in vivo, not specified in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:20.288257+00:00"}
{"study_id": 97704, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the chemopreventive potential of sulforaphane against carcinogen-induced oral cancer using in vitro and in vivo models, and to assess its bioavailability and pharmacodynamic activity in healthy volunteers.", "results_summary": "Sulforaphane induced NRF2 and its target genes, reduced pSTAT3 activity, and significantly decreased tumor incidence and size in mice. In humans, sulforaphane-rich broccoli sprout extract showed the greatest bioavailability, and mucosal bioactivity was observed in a subset of participants.", "population_specificity": "Healthy volunteers (10 participants) and murine models of oral cancer.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:21.322173+00:00"}
{"study_id": 97706, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the chemopreventive potential of sulforaphane on liver carcinogenesis through epigenetic mechanisms.", "results_summary": "The study suggests sulforaphane may reduce the occurrence or delay the development of hepatocellular carcinoma (HCC) by modifying deregulated epigenetic mechanisms, based on in vitro and in vivo models.", "population_specificity": "In vitro and in vivo models of hepatocellular carcinoma (HCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:22.548712+00:00"}
{"study_id": 97707, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review Sulforaphane's potential role in prostate cancer therapy, focusing on its molecular mechanisms and therapeutic strategies for resistant cases.", "results_summary": "Sulforaphane, as an HDAC inhibitor, shows promise in prostate cancer therapy by inducing cell growth arrest, differentiation, and apoptosis. Combined therapy enhances its efficacy, though its standalone effects are limited.", "population_specificity": "Prostate cancer (no specific patient demographics provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:23.719162+00:00"}
{"study_id": 97696, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if topical broccoli sprout extract (BSE), enriched for sulforaphane, could induce the expression of homologous keratins (K6, K17, K16) in human epidermis without affecting defective keratins (K5/K14) for potential therapeutic use in epidermolysis bullosa simplex.", "results_summary": "Topical BSE activated nuclear factor (erythroid-derived 2)-like 2 and upregulated K17 in all subjects, had variable effects on K16 and K6, and did not alter K14 or K5 expression. The study concluded BSE is a promising therapeutic candidate for K14-associated epidermolysis bullosa simplex.", "population_specificity": "Five subjects (34-71 years old), with one excluded due to poor tissue quality.", "effective_dosage": "500 nmol of sulforaphane/mL applied daily.", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:23.868223+00:00"}
{"study_id": 97709, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore sulforaphane's potential as a therapeutic agent for autism spectrum disorder (ASD) by targeting several physiological pathways associated with ASD.", "results_summary": "The study suggests sulforaphane may regulate key ASD-related pathways, including oxidative stress, mitochondrial dysfunction, immune dysregulation, heat shock response, and synaptic dysfunction, with potential to improve core and associated ASD symptoms. Biomarkers were identified to assess these pathways and guide treatment strategies.", "population_specificity": "Children with autism spectrum disorder (ASD).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:24.819348+00:00"}
{"study_id": 97708, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if ingestion of broccoli sprouts (a rich source of sulforaphane) improves airway inflammation, oxidative stress, and asthma symptoms in atopic adults with asthma.", "results_summary": "Despite increasing serum sulforaphane levels, 3-day broccoli sprout ingestion did not reduce airway inflammation (FENO), oxidative stress markers, or improve lung function or asthma symptoms. No significant changes in cytoprotective gene expression or inflammatory biomarkers were observed.", "population_specificity": "Adults aged 18-50 with asthma and allergic sensitization to an indoor allergen.", "effective_dosage": "100 g of broccoli sprouts daily.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:24.902582+00:00"}
{"study_id": 97710, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if sulforaphane (SFN) could safely activate NRF2 to restore oxidative capacity and increase fetal hemoglobin in sickle cell disease (SCD) patients.", "results_summary": "BSH containing SFN was well tolerated, increased HMOX1 mRNA levels significantly, and showed a trend toward increased HBG1 mRNA levels, but no significant changes in HbF protein were observed.", "population_specificity": "Adults with stable sickle cell disease (SCD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:25.931299+00:00"}
{"study_id": 97711, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Sulforaphane's potential as a chemoprevention agent against various cancers and other diseases, focusing on its mechanisms and clinical applications.", "results_summary": "Sulforaphane demonstrated broad-spectrum efficacy in preclinical models against multiple cancers, cardiovascular disease, neurodegenerative diseases, and diabetes, primarily through activation of the Nrf2-Keap1 pathway. Clinical studies utilized broccoli sprout preparations rich in Sulforaphane or its precursor, showing promising pharmacokinetic and pharmacodynamic profiles.", "population_specificity": "Preclinical models and clinical studies (specific human populations not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:29.783789+00:00"}
{"study_id": 97712, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare sulforaphane's ability to activate Nrf2 and induce cytoprotective genes with other phytochemicals, assessing its potential clinical efficacy as a complementary medicine.", "results_summary": "Sulforaphane was found to more potently activate Nrf2 and induce cytoprotective genes compared to other phytochemicals like curcumin, silymarin, and resveratrol, due to its high bioavailability and lipophilic nature. It favorably modified genes associated with chemoprevention, highlighting its therapeutic potential.", "population_specificity": "Not specified (general discussion of phytochemical effects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:30.648672+00:00"}
{"study_id": 97715, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to highlight the role of natural products, including sulforaphane, in cancer chemoprevention and therapy.", "results_summary": "The abstract emphasizes sulforaphane as a dietary phytochemical with potential chemopreventive properties, alongside other natural products, but does not provide specific study results on its effects.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:31.504013+00:00"}
{"study_id": 97713, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of sulforaphane, among other phytochemicals, in targeting cancer and cancer stem cells (CSCs) by interfering with self-renewal pathways and molecular mechanisms.", "results_summary": "The abstract suggests sulforaphane has anti-proliferative, anti-metastatic, ROS-inducing, anti-angiogenic, and pro-apoptotic effects, with efficacy in targeting CSCs and malignancy-related pathways. However, specific results for sulforaphane alone are not detailed.", "population_specificity": "Not specified (general discussion on cancer and CSCs).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:31.752162+00:00"}
{"study_id": 97714, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the anti-cancer activities of sulforaphane and other phytochemical-derived compounds, focusing on their cytotoxicity against tumors and potential combination strategies with other drugs.", "results_summary": "The abstract highlights sulforaphane as a bioactive marker for cytotoxicity against tumors but does not provide specific results on its efficacy or mechanisms. It emphasizes the need for further elucidation of its anti-cancer effects.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:31.888275+00:00"}
{"study_id": 97717, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Sulforaphane, via the Nrf2/ARE pathway, to protect mitochondrial function and mitigate oxidative stress in neurodegenerative diseases.", "results_summary": "Sulforaphane demonstrated promising protection of mitochondrial function in models of oxidative stress and neurodegenerative diseases, suggesting its potential as a preventive and therapeutic agent for aging-associated neurodegenerative conditions.", "population_specificity": "Models of oxidative stress and neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, Huntington's, ALS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:32.714163+00:00"}
{"study_id": 97716, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if sulforaphane could reverse detrimental changes associated with progerin expression and aging-related decline in neural stem cell function.", "results_summary": "The study suggests that sulforaphane, along with other compounds, partially reverses the detrimental effects of progerin expression in Hutchinson-Gilford progeria syndrome (HGPS) and may potentially restore stem cell function by addressing aging-associated permeability of the ER diffusion barrier.", "population_specificity": "Neural stem cells (NSCs) and cultured cells, with implications for aging and HGPS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:33.847589+00:00"}
{"study_id": 97718, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the hormetic effects of Sulforaphane (SFN) and its dual role in promoting cell survival or death depending on concentration and exposure time, particularly in cancer and immune-mediated diseases.", "results_summary": "The study highlights SFN's biphasic dose-response, showing pro-death effects at higher concentrations (cell cycle arrest, apoptosis) and pro-survival autophagy at lower concentrations. It underscores the need to understand the molecular mechanisms behind these divergent responses for therapeutic applications.", "population_specificity": "Not specified (in vitro and theoretical analysis based on literature review).", "effective_dosage": "Not specified (discusses concentration thresholds but no exact dosages).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:35.275510+00:00"}
{"study_id": 97719, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize evidence on how Sulforaphane activates Nrf2 and protects against cardiovascular disease through its antioxidant and anti-inflammatory properties.", "results_summary": "The study found that Sulforaphane activates Nrf2, inducing cytoprotective proteins that combat oxidative stress, and demonstrated potential benefits in cardiovascular disease through antioxidant and anti-inflammatory mechanisms.", "population_specificity": "Not specified (review of clinical studies and animal experiments).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:37.332400+00:00"}
{"study_id": 97720, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the mechanisms by which sulforaphane and other compounds up-regulate Nrf2 activity and their potential therapeutic applications in neurodegenerative conditions and cancer chemoprevention.", "results_summary": "The study found that sulforaphane up-regulates Nrf2 by covalently interacting with Keap1, inhibiting its activity, and that different classes of Keap1-Nrf2 inhibitors exhibit varying biological activities.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:39.199548+00:00"}
{"study_id": 97722, "supplement_id": 1591, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether sulforaphane could mitigate bronchoconstrictor responses to methacholine (MCh) and influence deep inspiration effects in moderate asthmatics.", "results_summary": "Sulforaphane significantly reduced bronchoconstriction in 60% of asthmatics but worsened it in 20%, highlighting response heterogeneity. It also improved airway resistance and luminal area in CT scans.", "population_specificity": "Moderate asthmatics (n=45)", "effective_dosage": "100 \u03bcmol daily", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:39.858238+00:00"}
{"study_id": 97723, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore non-apoptotic cell death mechanisms induced by plant-derived anticancer compounds, including sulforaphane, to identify novel molecular pathways for cancer therapeutics.", "results_summary": "The abstract highlights sulforaphane as a promising organosulfur compound with potential anticancer effects through alternative cell death mechanisms such as autophagy, necrosis-like programmed cell death, mitotic catastrophe, and senescence. However, specific results for sulforaphane are not detailed in the abstract.", "population_specificity": "Not specified (general focus on cancer therapeutics).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:40.690923+00:00"}
{"study_id": 97725, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cancer preventive and therapeutic efficacy of sulforaphane, focusing on its mechanisms of action, particularly the role of reactive oxygen species in promoting apoptosis and autophagy.", "results_summary": "The study found that sulforaphane exhibits cancer-preventive and therapeutic effects through multiple mechanisms, with reactive oxygen species generation playing a central role in inducing apoptosis and autophagy in target cells. The abstract highlights the toxicological relevance of sulforaphane-formed reactive oxygen species and the death pathways they trigger.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no human population details provided).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:42.603180+00:00"}
{"study_id": 97726, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the ability of sulforaphane and other phytochemicals to target and kill cancer stem cells (CSCs) by interfering with signaling pathways like Wnt.", "results_summary": "The study found that sulforaphane, among other phytochemicals, effectively kills CSCs by disrupting the Wnt pathway, demonstrating operatively efficient results both in vitro and in vivo.", "population_specificity": "Cancer stem cells (CSCs) in various cancer models (not specified for human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:43.695238+00:00"}
{"study_id": 97724, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between dietary cruciferous vegetable intake (a source of sulforaphane) and tumor biomarkers related to histone acetylation, proliferation, and cell-cycle regulation in breast tissue.", "results_summary": "Total cruciferous vegetable intake was inversely associated with Ki-67 protein expression in breast ductal carcinoma in situ (DCIS) tissue, suggesting reduced cell proliferation, but no associations were found for other biomarkers (HDAC3, HDAC6, H3K9, H3K18, p21) in benign or invasive ductal carcinoma (IDC) tissue.", "population_specificity": "Fifty-four women with abnormal mammogram findings scheduled for breast biopsy.", "effective_dosage": "Not specified (dietary intake measured, not supplemented dosage).", "study_duration": "Not specified (baseline data from a clinical trial).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:44.672165+00:00"}
{"study_id": 97727, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of Sulforaphane as an Nrf2 activator in mitigating oxidative stress and hyperglycemic damage related to diabetes and its complications.", "results_summary": "The study suggests Sulforaphane activates Nrf2, promoting antioxidant pathways to reduce oxidative stress and hyperglycemic damage, potentially aiding in diabetes control and complication prevention.", "population_specificity": "Prediabetic and diabetic individuals (general mention, no specific cohort detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:44.929818+00:00"}
{"study_id": 97730, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether sulforaphane (SFN) enhances temozolomide (TMZ)-induced apoptosis in glioblastoma (GBM) cells and to explore the underlying mechanism involving miR-21 and Wnt/\u03b2-catenin signaling.", "results_summary": "SFN significantly reduced miR-21 expression by inhibiting the Wnt/\u03b2-catenin/TCF4 pathway, which enhanced TMZ-induced apoptosis in GBM cells. The findings suggest SFN could be a potential adjuvant therapy to overcome TMZ resistance in GBM treatment.", "population_specificity": "Glioblastoma (GBM) cell lines", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:49.652298+00:00"}
{"study_id": 97729, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Sulforaphane protects human vascular endothelial cells from injury induced by lysophosphatidylcholine (LPC) by enhancing antioxidant capabilities mediated by Nrf-2 translocation.", "results_summary": "Sulforaphane significantly reduced ROS production, decreased MDA levels, restored SOD activity, and upregulated GST, GSH-Px, and TrxR expressions in a dose- and time-dependent manner. It also induced Nrf-2 translocation to the nucleus, unlike vitamin E, suggesting a unique mechanism for enhancing antioxidant defenses.", "population_specificity": "Human vascular endothelial EA.hy.926 cells", "effective_dosage": "0.5, 1.25, 2.5 \u03bcmol L(-1)", "study_duration": "12 h, 24 h, and 48 h", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:49.797962+00:00"}
{"study_id": 97728, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antimigratory and antimetastatic effects of natural products, including sulforaphane, on melanoma cells and map their mechanisms of action.", "results_summary": "Sulforaphane was identified as one of over 30 natural compounds that inhibit melanoma cell migration and metastasis, primarily by antagonizing TNF-\u03b1 and EP2 receptors, suppressing protein kinases (RAS, PI3K, ERK, FAK), and modulating biomarkers like N-cadherin and E-cadherin. It also inactivated transcription factors (NF-kB, AP-1, ATF-2, CREB, HIF), reducing the production of MMPs, IL-1, IL-6, COX-2, VEGF, and GM-CSF.", "population_specificity": "In vitro and in vivo melanoma cell models (specific human or animal details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:50.032435+00:00"}
{"study_id": 97732, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Sulforaphane's chemopreventive properties, including its effects on detoxification enzymes, anti-tumor action, and potential as an antioxidant dietary supplement.", "results_summary": "Sulforaphane induces Phase I and II detoxification enzymes, inhibits cancer cell viability, modifies epigenetic events, and exhibits anti-inflammatory effects. Its protective effects may be linked to Nrf2 activation, though further study is needed to understand molecular mechanisms.", "population_specificity": "Animal and human models (not specified in detail).", "effective_dosage": "Dose-dependent effects mentioned, but specific dosage not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:52.685740+00:00"}
{"study_id": 97733, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to identify natural compounds, including sulforaphane, that inhibit pathways contributing to cancer proliferation and progression.", "results_summary": "Sulforaphane was found to inhibit one or more pathways linked to cancer proliferation, such as hypoxia inducible factor 1, nuclear factor kappa B, and phosphoinositide 3 kinase/Akt. The study suggests sulforaphane may block tumor formation and progression by targeting these pathways.", "population_specificity": "Not specified (general cancer-related pathways)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:52.765745+00:00"}
{"study_id": 97731, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine if sulforaphane could slow the increase in PSA levels in prostate cancer patients with biochemical recurrence after radical prostatectomy.", "results_summary": "Sulforaphane did not meet the primary endpoint but showed significant secondary benefits, including slower PSA increases, longer PSA doubling time, and fewer patients with >20% PSA increases compared to placebo. Compliance and tolerance were very good.", "population_specificity": "78 prostate cancer patients (mean age 69 \u00b1 6 years) with increasing PSA levels after radical prostatectomy.", "effective_dosage": "60 mg of stabilized free sulforaphane daily.", "study_duration": "6 months of treatment followed by 2 months without treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:53.114218+00:00"}
{"study_id": 97734, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential of green chemoprevention, including Sulforaphane, as a safe and cost-effective option for reducing the incidence of head and neck squamous cell carcinoma (HNSCC).", "results_summary": "The abstract does not provide specific findings about Sulforaphane's effects but discusses the broader concept of green chemoprevention as a promising avenue for future studies in HNSCC prevention.", "population_specificity": "High-risk populations for head and neck squamous cell carcinoma (HNSCC).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:53.455093+00:00"}
{"study_id": 97737, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate evidence from human intervention studies on the effects of broccoli, glucoraphanin, and sulforaphane, focusing on clinical and molecular parameters of cell damage.", "results_summary": "The study found consistent improvements in blood glucose, lipid profile, and oxidative stress markers, but weaker evidence for effects on inflammation, Helicobacter pylori colonization, and cancer protection.", "population_specificity": "Humans (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:57.998357+00:00"}
{"study_id": 97736, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate sulforaphane's tumor cytotoxic effects, its ability to up-regulate NKG2D ligands, and its modulation of tumor cell susceptibility to NK cell-mediated killing.", "results_summary": "Sulforaphane increased MICA/MICB expression in A549 and MDA-MB-231 cells, enhancing their susceptibility to NK cell-mediated killing, which was ROS-dependent and blocked by N-acetyl cysteine. IR and SFN differentially induced NKG2D ligands across tumor cell lines.", "population_specificity": "Four tumor cell lines (MCF7, A549, MDA-MB-231, U937).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:58.859944+00:00"}
{"study_id": 97735, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a diet rich in high glucoraphanin broccoli reduces plasma LDL-cholesterol (LDL-C) compared to standard broccoli.", "results_summary": "High glucoraphanin broccoli significantly reduced plasma LDL-C by 7.1% in one study and 5.1% in another, while standard broccoli showed smaller, non-significant reductions. The combined data confirmed that high glucoraphanin broccoli had a significantly greater effect.", "population_specificity": "130 volunteers across two independent studies.", "effective_dosage": "400 g of high glucoraphanin or standard broccoli per week.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:25:58.986248+00:00"}
{"study_id": 97739, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 40, "quality_score": 70, "study_goal": "The researchers aimed to determine whether sulforaphane-rich extracts could significantly reduce PSA levels in men with recurrent prostate cancer.", "results_summary": "Only one patient experienced a \u226550% PSA decline, failing the primary endpoint, but seven had smaller declines. Treatment significantly lengthened PSA doubling time and was safe with no severe adverse events.", "population_specificity": "Men with recurrent prostate cancer (n=20).", "effective_dosage": "200 \u03bcmoles/day.", "study_duration": "Up to 20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:00.391985+00:00"}
{"study_id": 97721, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemopreventive effect of sulforaphane (SFN) on selective biomarkers in blood and breast tissues of women with abnormal mammograms.", "results_summary": "GFN supplementation significantly decreased Ki-67 and HDAC3 levels in benign breast tissue and reduced PBMC HDAC activity, but no significant changes were observed in other tissue biomarkers between treatment groups. The study concluded that short-term GFN supplementation is safe but may not sufficiently alter breast tissue tumor biomarkers.", "population_specificity": "54 women with abnormal mammograms scheduled for breast biopsy.", "effective_dosage": "Not specified (glucoraphanin supplement providing SFN).", "study_duration": "2 to 8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:00.842163+00:00"}
{"study_id": 97741, "supplement_id": 1591, "safety_score": "40", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential of sulforaphane (SFN) as a chemosensitizing agent to overcome apoptosis resistance in cancer treatment.", "results_summary": "The study highlights concerns about the safety and efficacy of SFN, noting unresolved issues and lack of evidence from randomized clinical trials supporting its effectiveness as an anticancer drug.", "population_specificity": "Not specified (preclinical and clinical relevance discussed generally).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:01.248116+00:00"}
{"study_id": 97740, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the biochemical and biological properties of sulforaphane, with a focus on its anticancer mechanisms and potential clinical utility.", "results_summary": "Sulforaphane shows promise in targeting cancer stem cells, reversing epigenetic alterations, and modulating key cellular mechanisms involved in carcinogenesis, including enzyme regulation, apoptosis, and cell cycle control. It exhibits selective toxicity to malignant cells while showing limited toxicity in normal tissues.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:01.759171+00:00"}
{"study_id": 97738, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the absorption and efficacy of sulforaphane (SFN) from myrosinase-treated broccoli sprout extract (BSE) compared to fresh broccoli sprouts, focusing on dosing schedules and bioavailability.", "results_summary": "SFN metabolite levels were ~3x higher in plasma and urine from sprout consumers than BSE, indicating better absorption from sprouts. Twelve-hour dosing maintained higher plasma SFN metabolite levels than 24-hour dosing, but no dose responses were observed for SFN's molecular targets.", "population_specificity": "Healthy adults", "effective_dosage": "200 \u03bcmol SFN daily (single dose or two 100-\u03bcmol doses 12h apart)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:01.936039+00:00"}
{"study_id": 97742, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sulforaphane, derived from broccoli sprout extracts, could improve behavioral symptoms in young men with moderate to severe autism spectrum disorder (ASD).", "results_summary": "Sulforaphane significantly improved behavioral measures (ABC, SRS, CGI-I) compared to placebo, with 34% improvement in ABC scores and 17% in SRS scores. Behavioral benefits diminished after discontinuation of treatment.", "population_specificity": "Young men aged 13-27 with moderate to severe ASD.", "effective_dosage": "50-150 \u00b5mol daily.", "study_duration": "18 weeks of treatment, followed by 4 weeks without treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:06.675270+00:00"}
{"study_id": 97744, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could block oxidative metabolism of estradiol/estrone (E2/E1) and prevent DNA damage, potentially reducing breast cancer risk.", "results_summary": "Sulforaphane increased expression of protective enzymes (NQO1 and GSTA1) and reduced depurinating DNA adducts while increasing estrogen-quinone conjugates, suggesting a protective effect against estrogen-induced DNA damage and neoplastic transformation.", "population_specificity": "MCF-7, MCF-10A, and MCF-10F cell lines (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:08.265515+00:00"}
{"study_id": 97743, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane from broccoli sprout extract (BSES) could inhibit Helicobacter pylori infection density and exert antioxidative effects on gastric mucosal damage.", "results_summary": "BSES did not significantly reduce H. pylori infection density or ammonia concentration but significantly lowered oxidative damage (MDA) in the gastric mucosa, suggesting a cytoprotective role in H. pylori-induced gastritis.", "population_specificity": "H. pylori-positive and H. pylori-negative subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:08.480024+00:00"}
{"study_id": 97746, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of sulforaphane in reducing the risk of prostate cancer progression through its effects on redox status and metabolism.", "results_summary": "The study suggests that sulforaphane creates a tissue environment unfavorable for prostate cancer progression by influencing redox status and metabolism, supported by evidence from human intervention studies.", "population_specificity": "Individuals at risk of prostate cancer progression (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:08.692120+00:00"}
{"study_id": 97745, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of NRF2 activators, including sulforaphane, in protecting against kidney dysfunction in chronic kidney disease (CKD) models.", "results_summary": "The study found that sulforaphane and other NRF2 activators show renoprotective effects in experimental CKD models by counteracting oxidative stress and maintaining cellular redox homeostasis. These findings suggest potential benefits in ameliorating CKD progression.", "population_specificity": "Experimental CKD models (animal studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:09.043353+00:00"}
{"study_id": 97747, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess sulforaphane's efficacy in reducing inflammation and promoting neuroprotection after spinal cord injury, compared to IL-10 and other herbal extracts.", "results_summary": "Sulforaphane showed acceptable but weaker anti-inflammatory and neuroprotective effects compared to IL-10, with outcomes deemed acceptable but less robust.", "population_specificity": "Individuals with spinal cord injury (animal or human models not specified in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:09.610386+00:00"}
{"study_id": 97748, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the pharmacodynamic action of a broccoli sprout-derived beverage (containing glucoraphanin and sulforaphane) in enhancing detoxification of airborne pollutants.", "results_summary": "The study found rapid and sustained increases in urinary excretion of glutathione-derived conjugates of benzene (61%) and acrolein (23%), indicating enhanced detoxification. Bioavailability of sulforaphane metabolites remained stable over the 12-week dosing period.", "population_specificity": "291 participants from rural He-He Township, Qidong, China, an area with high airborne pollutant exposure.", "effective_dosage": "Daily doses of 600 \u03bcmol glucoraphanin and 40 \u03bcmol sulforaphane.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:12.197335+00:00"}
{"study_id": 97749, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to test the feasibility of a randomized controlled trial using freeze-dried broccoli sprouts (containing sulforaphane) in patients with advanced pancreatic ductal adenocarcinoma (PDA) to assess its potential as a supportive treatment alongside palliative chemotherapy.", "results_summary": "The study found that sulforaphane, derived from broccoli sprouts, reduced tumor growth and enhanced cancer cell sensitivity to chemotherapy in experimental studies, but clinical results from this pilot trial are pending. The trial will assess feasibility, adverse effects, compliance, tumor markers, quality of life, and survival rates.", "population_specificity": "Adults (18+) with advanced, non-resectable PDA undergoing palliative chemotherapy.", "effective_dosage": "90 mg of active sulforaphane daily (15 capsules).", "study_duration": "One year (follow-up duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:12.532845+00:00"}
{"study_id": 97750, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sulforaphane could counteract the absence of Cx43, improve gap junctional intercellular communication (GJIC), and reduce cancer stem cell (CSC) markers in pancreatic ductal adenocarcinoma (PDA).", "results_summary": "Sulforaphane enhanced Cx43 and E-cadherin levels, inhibited CSC markers (c-Met and CD133), improved GJ morphology and function, and altered kinase phosphorylation patterns, suggesting it may counteract PDA aggressiveness. The effects were linked to posttranslational phosphorylation rather than transcriptional or epigenetic changes.", "population_specificity": "Pancreatic ductal adenocarcinoma (PDA) cells, including established and primary cancer cells, and patient tissue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:16.245505+00:00"}
{"study_id": 97752, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the chemopreventive potential of Sulforaphane, focusing on its mechanisms and efficacy in cancer prevention.", "results_summary": "The abstract highlights Sulforaphane as a promising chemopreventive agent, classified among sulphur-containing compounds, with potential to inhibit carcinogenesis by targeting cell proliferation, apoptosis, and angiogenesis. However, specific efficacy data for Sulforaphane alone are not detailed.", "population_specificity": "High-risk populations for cancer (general, not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:17.301887+00:00"}
{"study_id": 97751, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential of sulforaphane as a dietary antioxidant for attenuating traumatic brain injury (TBI)-induced damage, focusing on its mechanisms involving NRF2 activation and carbonyl scavenging.", "results_summary": "The study found that sulforaphane, along with other dietary antioxidants, can attenuate TBI-induced damage in preclinical studies by enhancing antioxidant defenses via NRF2 activation and acting as a carbonyl scavenger. However, clinical consolidation of these findings is still needed.", "population_specificity": "Preclinical studies (not specified if human or animal models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:17.483037+00:00"}
{"study_id": 97753, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the preventive and therapeutic effects of isothiocyanates (ITCs), including sulforaphane, in cancer.", "results_summary": "The study found that ITCs, derived from cruciferous vegetables, exhibit anticancer effects by suppressing tumor growth through reactive oxygen species generation and cell cycle arrest leading to apoptosis. Preclinical and limited clinical data suggest ITCs are promising natural anticancer agents.", "population_specificity": "Not specified (review of preclinical and available clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:18.274474+00:00"}
{"study_id": 97755, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether a validated sulforaphane-yielding broccoli sprout supplement could deliver clinical benefits by activating Nrf2-mediated cytoprotective pathways.", "results_summary": "The study highlights that sulforaphane, derived from broccoli sprouts, effectively induces Nrf2, enhancing cellular defense mechanisms, but notes inconsistencies in supplement labeling and the necessity of active myrosinase for bioactivity. Many supplements lack active myrosinase, potentially reducing efficacy.", "population_specificity": "Not specified (general human consumption implied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:18.347401+00:00"}
{"study_id": 97754, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a standardized broccoli sprout extract (BSE) containing sulforaphane (SFN) could suppress nasal inflammatory responses in humans exposed to diesel exhaust particles (DEP).", "results_summary": "The study found that daily BSE administration for four days reduced total nasal white blood cell counts by 54% after DEP challenge, demonstrating significant anti-inflammatory effects. The SFN dose was equivalent to consuming 100-200 g of broccoli, suggesting preventive and therapeutic potential against particulate pollution-induced allergic disease and asthma.", "population_specificity": "29 human subjects exposed to diesel exhaust particles.", "effective_dosage": "100 \u03bcmol SFN daily in mango juice.", "study_duration": "4 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:18.608865+00:00"}
{"study_id": 97756, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review recent advances in the epigenetic effects of dietary interventions, including sulforaphane, on cancer and aging.", "results_summary": "The study found that sulforaphane, derived from cruciferous vegetables, has anticancer epigenetic effects and may help prevent or treat epigenetic aberrations in age-associated diseases. Dietary control, including phytochemicals like sulforaphane, shows promise in reversing epigenetic changes linked to cancer and aging.", "population_specificity": "Not specified (general discussion on cancer and aging).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:20.548913+00:00"}
{"study_id": 97757, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Sulforaphane's potential as a chemopreventive and chemotherapeutic agent in cancer, focusing on its molecular targets and effects in various models.", "results_summary": "Sulforaphane demonstrated potent cytostatic and cytotoxic effects, modulated multiple molecular targets, and enhanced chemotherapy efficacy in vitro. It showed effectiveness in cell cultures, animal models, and xenografts, independent of p53 mutation status.", "population_specificity": "Cell cultures, carcinogen-induced and genetic animal cancer models, and xenograft models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:20.897662+00:00"}
{"study_id": 97758, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical relevance and mechanisms of sulforaphane as a chemopreventive agent for prostate cancer.", "results_summary": "The abstract mentions sulforaphane as a promising nutraceutical for prostate cancer chemoprevention, but notes that further studies are needed to confirm clinical efficacy and safety. No specific results for sulforaphane are detailed.", "population_specificity": "Men with an increased risk of prostate cancer (suggested for future trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:24.389809+00:00"}
{"study_id": 97760, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's neuroprotective effects and its potential role in preventing neurodegeneration by activating the Nrf2/ARE pathway.", "results_summary": "Sulforaphane demonstrated neuroprotective effects in in vitro and in vivo studies, primarily through activation of the Nrf2/ARE pathway, suggesting promise for preventing neurodegeneration in conditions like Alzheimer's and Parkinson's disease.", "population_specificity": "Not specified (in vitro and in vivo studies, no human population detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:25.848424+00:00"}
{"study_id": 97759, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could activate the Nrf2-ARE pathway to reduce oxidative stress and apoptosis in Fuchs endothelial corneal dystrophy (FECD).", "results_summary": "Sulforaphane decreased apoptosis in FECD specimens by 55% in unstressed conditions and 43% under oxidative stress, enhanced Nrf2 nuclear translocation, reduced p53 staining, and upregulated key antioxidants, demonstrating protective effects against oxidative damage.", "population_specificity": "Patients with Fuchs endothelial corneal dystrophy (FECD) and human corneal endothelial cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:26.926468+00:00"}
{"study_id": 97762, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of sulforaphane from young broccoli sprouts as a supplementary treatment for type 2 diabetes and its complications by examining its antioxidant, anti-inflammatory, and metabolic effects.", "results_summary": "Sulforaphane demonstrated significant benefits, including increased plasma antioxidant capacity, reduced oxidative stress, improved lipid and glucose metabolism, and decreased inflammatory markers in type 2 diabetics. It also showed potential in preventing diabetic complications like nephropathy and vascular issues.", "population_specificity": "Type 2 diabetics", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:27.195327+00:00"}
{"study_id": 97761, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemopreventive and antitumor properties of sulforaphane, focusing on its effects on various cancer cell lines and its potential mechanisms of action.", "results_summary": "Sulforaphane demonstrated dose-dependent inhibition of cell viability in multiple human cancer cell lines (cervical, pancreatic, hepatocellular, ovarian) and exhibited anti-inflammatory properties in T-cell leukemia cells. The protective effects may be linked to improved antioxidant status, though molecular mechanisms and dietary interactions remain incompletely understood.", "population_specificity": "Human cancer cell lines (in vitro study)", "effective_dosage": "Dose-dependent (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:27.377297+00:00"}
{"study_id": 97764, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Sulforaphane as a natural activator of the Keap1-Nrf2 pathway and its potential therapeutic applications.", "results_summary": "Sulforaphane was identified as a natural activator of the Keap1-Nrf2 pathway, which regulates antioxidant and anti-inflammatory responses. The study suggests pharmacological activation of this pathway could be beneficial for disease treatment and prevention.", "population_specificity": "Not specified (general mechanism discussed, no specific population studied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:29.596204+00:00"}
{"study_id": 97765, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of sulforaphane (SFN) and phenethyl ITCs (PEITC) on TLR3-mediated innate immune signaling and their implications for antitumor activity.", "results_summary": "SFN inhibited TLR3-mediated NF-\u03baB signaling and downstream gene expression, enhancing dsRNA-mediated apoptosis of tumor cells and inhibition of colony formation in immortalized fibroblasts. Unlike PEITC, SFN did not disrupt TLR3 dimerization but acted further downstream.", "population_specificity": "In vitro and in vivo models (specific human population not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:29.945409+00:00"}
{"study_id": 97766, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mode of action of PXR antagonists, including sulforaphane, and develop less-toxic PXR antagonists.", "results_summary": "The study found that sulforaphane acts as a PXR antagonist, but its mode of action remains unclear. Preliminary findings suggest potential for developing more selective PXR antagonists for clinical use.", "population_specificity": "Not specified (laboratory-focused research).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:32.239613+00:00"}
{"study_id": 97767, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare how arsenic and natural compounds like sulforaphane activate the Nrf2-Keap1 pathway and their implications in toxicity and carcinogenicity.", "results_summary": "The study found that sulforaphane activates the Nrf2 pathway differently than arsenic and may protect against arsenic-induced toxicity and carcinogenicity. It also suggested that prolonged Nrf2 activation by arsenic could contribute to cancer, while chemopreventive compounds like sulforaphane offer protective effects.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:35.232736+00:00"}
{"study_id": 97769, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sulforaphane could modulate inflammation and apoptosis in rheumatoid arthritis by affecting Nrf2, NF-\u03baB, and AP-1 pathways in synoviocytes.", "results_summary": "Sulforaphane reduced inflammation and proliferation in TNF-\u03b1-stimulated synoviocytes but did not significantly affect MMP-3 and MMP-9 activity. It activated Nrf2 in na\u00efve cells while inducing apoptosis in inflamed cells.", "population_specificity": "Cultured synoviocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:35.788963+00:00"}
{"study_id": 97770, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether selenium and/or isothiocyanates (including sulforaphane) could impact DNA methylation processes in colorectal carcinoma cell lines.", "results_summary": "The study found no significant effects on gene-specific or global DNA methylation patterns in colorectal cancer cells treated with sulforaphane, either alone or in combination with selenium. Only transient changes in DNMT mRNA expression were observed, without altering the aberrant methylation status of the cells.", "population_specificity": "Colorectal carcinoma cell lines (Caco-2 and HCT116)", "effective_dosage": "6 to 8 \u03bcM sulforaphane", "study_duration": "Up to 12 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:36.153247+00:00"}
{"study_id": 97763, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore Sulforaphane's potential as an anticancer agent by examining its effects on epigenetic modifications and cancer stem cells.", "results_summary": "The study found that Sulforaphane exhibits anticancer properties by altering epigenetic processes (DNA methylation, histone modification, miRNA regulation) and targeting cancer stem cells, showing efficacy in vitro and in vivo across various cancers.", "population_specificity": "Not specified (in vitro and in vivo models, likely including various cancer types).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:36.496590+00:00"}
{"study_id": 97771, "supplement_id": 1591, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the bioavailability, tolerability, and pharmacodynamic action of sulforaphane-rich broccoli sprout beverages in enhancing detoxication of carcinogens like aflatoxins and air-borne toxins.", "results_summary": "The study found that sulforaphane interventions enhanced detoxication of aflatoxins and air-borne toxins, potentially reducing associated health risks like cancer. Clinical trials indicated bioavailability and tolerability of broccoli sprout preparations.", "population_specificity": "Residents of Qidong, China, a region with high exposure to food- and air-borne carcinogens.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:38.426610+00:00"}
{"study_id": 97772, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the beneficial effects of glucosinolates and isothiocyanates, particularly sulforaphane, in animal models of carcinogenesis, cardiovascular and neurological diseases, and human intervention studies.", "results_summary": "The study highlights sulforaphane's potent induction of cytoprotective proteins via the Keap1-Nrf2-ARE pathway, demonstrating beneficial effects in disease models and human intervention studies regarding safety, pharmacokinetics, and efficacy.", "population_specificity": "Animal models and human intervention studies (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:39.690737+00:00"}
{"study_id": 97773, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate sulforaphane as a potential anti-cancer stem cell (CSC) therapy by targeting key pathways involved in CSC properties.", "results_summary": "Sulforaphane was identified as one of several promising drugs targeting CSCs, with potential effects on self-renewal pathways, drug resistance, and other CSC features, though clinical progression remains uncertain.", "population_specificity": "Not specified (general focus on cancer stem cells in various solid tumors and leukemias).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:40.399722+00:00"}
{"study_id": 97775, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a more sensitive assay to detect reversible modifications of Keap1 by electrophiles like sulforaphane, to identify potential chemoprevention agents in natural product mixtures.", "results_summary": "The study validated the new assay using sulforaphane, demonstrating its ability to detect reversible Keap1 modifications, and successfully identified sulforaphane in a complex cocoa extract using LC-MS/MS.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:43.462490+00:00"}
{"study_id": 97774, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of sulforaphane and other nutrients in modulating epigenetic mechanisms to influence prostate cancer susceptibility and progression.", "results_summary": "The study highlights sulforaphane as a dietary phytochemical that affects epigenetic events, such as DNA methylation and histone modifications, which can alter gene expression and potentially influence prostate cancer progression. It positions sulforaphane among promising agents for cancer chemoprevention.", "population_specificity": "Focused on prostate cancer susceptibility, but no specific demographic details provided.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:43.861161+00:00"}
{"study_id": 97777, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential of sulforaphane, a bioactive dietary component, to modulate epigenetic events associated with breast cancer prevention and therapy.", "results_summary": "The abstract suggests that sulforaphane, along with other bioactive dietary components, can modulate epigenetic events linked to breast cancer, offering potential therapeutic or preventive benefits. However, specific results for sulforaphane alone are not detailed.", "population_specificity": "General mention of Asian populations with high consumption of bioactive dietary components, but no specific population studied for sulforaphane.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:45.817265+00:00"}
{"study_id": 97776, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the pharmacodynamic action of sulforaphane-rich and glucoraphanin-rich broccoli sprout beverages in enhancing detoxification of airborne pollutants.", "results_summary": "The study found statistically significant increases (20-50%) in urinary excretion of glutathione-derived conjugates of acrolein, crotonaldehyde, and benzene after intervention with sulforaphane-rich or glucoraphanin-rich beverages, indicating enhanced detoxification. No significant differences were observed between the effects of the two beverages.", "population_specificity": "Healthy participants from a farming community in He Zuo Township, Qidong, China, with high exposure to aflatoxin and airborne pollutants.", "effective_dosage": "Not specified", "study_duration": "7 days per beverage (with a 5-day washout period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:45.939346+00:00"}
{"study_id": 97768, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sulforaphane could effectively antagonize ligand activation of human PXR in vivo, using rifampicin as a PXR ligand and midazolam as a CYP3A activity marker.", "results_summary": "Sulforaphane did not reduce CYP3A4 induction when co-administered with rifampicin, nor did it affect CYP3A4 activity in the overall cohort, though it significantly decreased CYP3A4 activity in a subset with high basal activity. Humanized PXR mice showed similar results, validating the model.", "population_specificity": "24 healthy adults", "effective_dosage": "450 \u03bcmol daily (Broccoli Sprout extract)", "study_duration": "7 days per treatment arm", "interactions": "Rifampicin (PXR ligand) and midazolam (CYP3A marker)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:46.116423+00:00"}
{"study_id": 97778, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review and summarize existing research on Sulforaphane's chemopreventive properties, including its antioxidant, anticarcinogenic, and anti-inflammatory functions, as well as its metabolism, stability, and formulation developments.", "results_summary": "The study found that Sulforaphane exhibits significant chemopreventive properties, including antioxidant, anticarcinogenic, and anti-inflammatory effects, and highlighted the need for further research on its metabolism and stability for future applications.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:47.135194+00:00"}
{"study_id": 97779, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to examine the potential of sulforaphane, among other nutrients, for treating obesity in critically ill ICU patients.", "results_summary": "The abstract suggests sulforaphane could be beneficial for obese ICU patients, but no specific results or outcomes related to sulforaphane are detailed. It is grouped with other nutrients that may improve ICU outcomes.", "population_specificity": "Obese patients in the intensive care unit (ICU).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:47.619530+00:00"}
{"study_id": 97780, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to develop a sensitive LC-MS/MS method for quantifying sulforaphane and indole-3-carbinol metabolites in plasma and urine after dietary intake of regular and selenium-fertilized broccoli.", "results_summary": "The study found that selenium-fertilized broccoli increased serum selenium levels by up to 25% but did not affect glucosinolate metabolite concentrations in plasma or urine compared to regular broccoli.", "population_specificity": "76 healthy volunteers", "effective_dosage": "200 g of regular or selenium-fertilized broccoli daily", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:48.608032+00:00"}
{"study_id": 97782, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent findings on how sulforaphane, a natural compound, may enhance the therapeutic effects of conventional cancer treatments by examining its molecular mechanisms.", "results_summary": "The abstract suggests that sulforaphane has distinct anticarcinogenic activity and may potentiate the anti-tumor effects of various cancer therapies, though specific results are not detailed.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:51.482419+00:00"}
{"study_id": 97781, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of sulforaphane as an extrinsic regulator targeting TLR dimerization to modulate PRR signaling pathways and control inflammatory diseases.", "results_summary": "The study suggests sulforaphane may inhibit TLR dimerization, potentially regulating excessive PRR activation linked to chronic inflammatory diseases, though specific efficacy data is not detailed.", "population_specificity": "Not specified (theoretical or in vitro/in vivo models implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:51.676535+00:00"}
{"study_id": 97784, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review Sulforaphane's impact on cancer stem cell self-renewal pathways and its potential effects against cancer stem cells.", "results_summary": "Sulforaphane was reported to inhibit pancreatic tumor-initiating cells and breast cancer stem cells, suggesting potential efficacy in targeting cancer stem cells through self-renewal pathways.", "population_specificity": "Pancreatic tumor-initiating cells and breast cancer stem cells (in vitro/in vivo studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:54.017645+00:00"}
{"study_id": 97785, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the differential effects of Sulforaphane on colon cancer cells (HCT116) versus normal colon cells (NCM460), focusing on cell proliferation, apoptosis, and signaling pathways.", "results_summary": "Sulforaphane inhibited cell proliferation by up to 95% in colon cancer cells and 52% in normal cells, induced apoptosis in cancer cells, and differentially activated survival signaling in normal cells and apoptotic signaling in cancer cells.", "population_specificity": "Colon cancer cells (HCT116) and normal colon mucosa-derived cells (NCM460).", "effective_dosage": "5, 10, and 15 \u03bcmol/L.", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:55.205382+00:00"}
{"study_id": 97783, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the bioavailability and tolerability of sulforaphane from two broccoli sprout-derived beverages (glucoraphanin-rich and sulforaphane-rich) in healthy participants.", "results_summary": "The sulforaphane-rich beverage showed substantially greater bioavailability (mean = 70% urinary excretion) compared to the glucoraphanin-rich beverage (mean = 5%), with lower interindividual variability and different elimination rates suggesting potential for tailored dosing strategies.", "population_specificity": "50 healthy adults who refrained from crucifer consumption.", "effective_dosage": "Not specified in the abstract.", "study_duration": "7-day administration periods for each beverage, with a 5-day washout in between.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:55.443414+00:00"}
{"study_id": 97787, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate sulforaphane's potential as a \u03b2-catenin inhibitor targeting tumor-initiating cells (TICs) in breast cancer.", "results_summary": "Sulforaphane demonstrated toxicity against chemotherapy-resistant subpopulations of cancer cells (TICs), suggesting potential efficacy in targeting these cells. The study did not provide detailed efficacy metrics but included it among other promising agents.", "population_specificity": "Breast cancer tumor-initiating cells (TICs) in immunocompromised mice and clinical samples.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:56.423506+00:00"}
{"study_id": 97786, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the absorption of Sulforaphane from myrosinase-rich broccoli sprouts versus a glucoraphanin-rich broccoli powder lacking myrosinase, both individually and in combination.", "results_summary": "The study found that Sulforaphane absorption was highest from broccoli sprouts (74% urinary recovery), followed by the combination (49%), and lowest from the broccoli powder alone (19%). Plasma and urinary ITC appearance was delayed with the broccoli powder, but combining it with sprouts enhanced absorption. No toxicity was observed at 24 hours.", "population_specificity": "4 subjects (specific demographics not provided).", "effective_dosage": "2 g of broccoli sprouts, 2 g of broccoli powder, or both, consumed with dry cereal and yogurt.", "study_duration": "Single administration with 24-hour follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:57.826598+00:00"}
